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ChapterGeneral
introduction
“Dovie’andi se tovya sagain.” (transl: “It’s time to toss the dice”) 
Mat Cauthon (The Wheel of Time - Robert Jordan)
10 11
Cocaine and addiction 
Cocaine is derived from the Erytroxylon Coca plant native to western South America. 
The substance was brought to Europe in the second half of the 19th century where it 
gained popularity as a local analgesic and as a supposed cure for myriad of conditions 
(Gootenburg, 2002). Currently, cocaine is almost exclusively used for recreational 
purposes and is registered as an illegal drug in most of the world due to its addictive 
properties. The habitual use of cocaine remains a pressing health and social concern. 
According to the European Monitoring Centre for Drugs and Drug Addiction, 5.2% of 
Europeans have used cocaine at least once during their lifetime, making it the second 
most used illicit drug in Europe after cannabis (EMCDDA, 2017). Additionally, annual 
costs of addiction across Europe are estimated at €65.7 billion, making it the 5th 
(out of 19) most expensive brain disorder group (Gustavsson et al., 2011; Olesen et 
al., 2012). This estimate, while impressive, is likely an underestimation as it includes 
direct healthcare costs as well as non-medical costs such as absenteeism, but does not 
include costs associated with crime, which can be assumed to be disproportionally high 
in addiction (Gustavsson et al., 2011). 
According to the Diagnostic and Statistical Manual of Mental disorders 5th edition (DSM-V), 
addiction or substance abuse disorders (SUDs) are characterized by an expanding cycle 
of dysfunction in the brain, leading to compulsive drug use, i.e. perseveration of drug use 
despite long-term negative consequences (DSM-5, 2013). Cocaine addiction is often co-
morbid with other diseases such as other addictions 
(poly-substance use), post-traumatic stress disorder (PTSD), depression, anxiety 
disorders and attention deficit hyperactivity disorder (ADHD) which may suggest that 
similar neurocircuitries are involved in the psychopathology of these diseases (Anderson 
et al., 2018; Lee et al., 2011; Read et al., 2004). Despite the strong reinforcing properties 
experienced upon use, only 20-40% of individuals exposed to a drug of abuse escalate 
to true addictive behavior (Lopez-Quintero et al., 2011; 
Wagner and Anthony, 2002). This suggests that individual differences play a significant 
role in the progression from occasional drug use to true addiction. It is currently 
thought that this transition is regulated by the type of drug, genetic predisposition and 
environmental factors (Kreek et al., 2002). The latter includes prenatal exposure to drugs 
of abuse, which may increase vulnerability to addiction due to neurodevelopmental 
changes. Additionally, environmental risk factors also involve a persons’ social network 
or the exposure/processing of drug associated stimuli 
(Kreek et al., 2002). So far the pharmacological treatment of cocaine addiction has been 
largely unsuccessful, while cognitive behavioral therapy is only effective in approximately 
30% of treated patients (Dutra et al., 2008). Therefore, a better understanding of the 
factors that contribute to developing addiction (e.g. genetics) 
and factors contributing to extinction and preventing relapse of drug seeking behavior 
(e.g. drug associated stimuli) are paramount to developing new treatments. 
Brain circuitry of drug addiction
The development of addiction is complex and involves many processes including reward, 
mood, memory and cognition. It is therefore not surprising that the neurocircuitry of 
addiction reflects these different processes. While an extensive report of all involved 
brain areas and their interactions is outside the scope of this chapter, a brief overview 
is warranted (For extensive reviews see: Jasinska et al., 2014; Koob and Volkow, 2016; 
Volkow and Morales, 2015). The mesolimbic system, consisting of the ventral tegmental 
area (VTA) and nucleus accumbens (NAc), mediates the rewarding properties of 
rewarding stimuli like cocaine. When addiction transitions from goal-directed (reward 
driven) to habitual behavior, a shift is seen from the involvement of the ventral striatum 
to the dorsal striatum (Everitt and Robbins, 2013). Functional MRI studies have shown 
that the dorsal striatum, NAc, VTA, prefrontal cortex (PFC) cerebellum, amygdala, 
hippocampus and insula all increase in activity when a drug user is exposed to drug 
associated stimuli, which induces craving and can initiate drug seeking or relapse 
(Goudriaan et al., 2013; Jasinska et al., 2014). Conversely, control over these cues, 
through executive function, is often lowered in drug addicts and attributed to different 
parts of the prefrontal cortex including the anterior cingulate cortex (ACC), lateral orbital 
frontal cortex (OFC) and infralimbic prefrontal cortex PFC (IL) (Peters et al., 2009; Volkow 
and Fowler, 2000; Volkow and Morales, 2015). Additionally, avoidance of a negative 
emotional state (withdrawal) is a driving factor in addiction. The extended amygdala, 
consisting of the central nucleus of the amygdala (CeA), the bed nucleus of the stria 
terminalis (BNST) and the shell of the NAc, have been implicated in this, as well as a loss 
of function of the VTA (Koob, 2013). Worth mentioning here is that it recently has been 
found that most monosynaptic glutamatergic input to dopaminergic VTA cells arises from 
the dorsal raphe nucleus (DRN) (Ogawa et al., 2014), which may serve as a driving factor 
in reward seeking.
Neurotransmitters and drug addiction
During neural transmission neurotransmitters are emitted from the presynaptic terminal, 
cross the synaptic cleft and bind receptors on the postsynaptic terminal to propagate an 
action potential, and alter gene expression. After signal transduction, transporter proteins 
on the presynaptic terminal reabsorb neurotransmitters from the synaptic cleft into the 
presynaptic neuron for reuse. Cocaine primarily acts by blocking the serotonin (5-HT), 
noradrenaline (NA) and dopamine (DA) transporters (5-HTT, NAT and DAT, respectively), 
hereby increasing the extracellular concentration of these monoamines. Recent studies 
also point towards a direct monoamine releasing action of cocaine (Verheij et al., 2018, 
Submitted). While classically, most rewarding properties of cocaine are specifically 
attributed to increased DA in the reward circuitries of the brain (specifically the ventral 
striatum), there is also evidence that release of NA and 5-HT can directly enhance cocaine Ch
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reinforcement (Pentkowski et al., 2009; Shi et al., 2000). However, on the behavioral 
level, the motivation to take the drug shifts from experiencing the reinforcing properties of 
DA (positive reinforcement) to avoiding negative emotions experienced during withdrawal 
(negative reinforcement). While the mechanisms underlying this negative emotional 
state (NES) are not fully understood, it is a process in which the serotonergic system is 
thought to play an important role (Verheij et al., 2017). Hence, research into the role of 
5-HT in addiction may yield new understandings for both the cause and cure of cocaine 
addiction. 
Role of drug associated stimuli in drug addiction
Pavlovian learning of cocaine associated stimuli, named after the infamous Ivan Pavlov 
(1849-1936), contributes to cocaine-taking behavior escalating to chronic cocaine use 
(Everitt et al., 2008; Everitt et al., 2001). During Pavlovian conditioning, a conditioned 
stimulus (CS) is coupled to an unconditioned stimulus (US), which then evokes a 
conditioned response (CR) (Pavlov, 1927). For example, in a laboratory setting, a signal 
light (CS) is coupled to the taking of cocaine (US), which evokes a typical drug response 
(CR). After repeated exposures of CS-US pairings, the CS itself can become salient and 
drive drug seeking behavior and a transition to chronic cocaine use (Everitt et al., 2008). 
Typically, the way to diminish Pavlovian learned behavior is by extinction (exposure 
therapy in humans). During extinction, the CS is repeatedly presented in the absence of 
US and a new, hopefully dominant, memory trace is formed that diminishes the behavioral 
expression of the unwanted CS-US association. In fear conditioning, a paradigm often 
used to study Pavlovian mechanisms, the medial prefrontal cortex (mPFC) is responsible 
for this executive function by stimulation of GABAergic intercalated cells in the amygdala, 
which in turn inhibit the central nucleus of the amygdala which is responsible for driving 
expression of CS-US behavior (Peters et al., 2009). It is thought that the mPFC serves a 
similar function in control of drug-seeking behavior by inhibiting both the amygdala and 
striatal regions (Everitt and Robbins, 2005; Peters et al., 2009; Van den Oever et al., 2010). 
In line with this, exposure therapy is seen as the first line treatment of anxiety related 
disorders such as PTSD (Rauch et al., 2012), and cocaine addictive disorder (Penberthy 
et al., 2010). The projections from the mPFC are glutamatergic and are essential for the 
consolidation of extinction learning (Burgos-Robles et al., 2007; LaLumiere et al., 2010). 
However, drug associated cues have been proven to be notoriously hard to extinguish, 
and are fundamental in causing relapse (Crombag et al., 2008; Penberthy et al., 2010).
Putative therapeutic effect of D-cycloserine 
Extensive research has gone into increasing extinction learning and preventing relapse 
through behavioral and pharmacological means. Relevant to the work discussed in this 
thesis are pharmacological administration of D-cycloserine (DCS) to enhance extinction 
consolidation and behavioral counter-conditioning to reduce reinstatement (see chapters 
4 and 5). DCS acts as a partial N-Methyl-D-aspartic acid (NDMA) receptor agonist, 
binding the glycine site of the NR1 receptor subunit, increasing likelihood of receptor 
activation. Previous research has shown that NMDA dependent bursting of the mPFC 
is necessary for extinction learning (Burgos-Robles et al., 2007), and DCS has shown 
promise in preclinical studies in reducing drug seeking after extinction (Botreau et al., 
2006; MacKillop et al., 2015; Santa Ana et al., 2009). However, this effect has not been 
replicated in all studies (Kennedy et al., 2012; Price et al., 2013; Prisciandaro et al., 
2013; Santa Ana et al., 2015), suggesting individual differences may play a role in the 
effectiveness of this cognitive enhancer (De Kleine et al., 2014). 
Putative therapeutic effect of counter-conditioning
Counter-conditioning is a behavioral approach to enhance extinction and reduce 
reinstatement of drug seeking. Counter-conditioning differs from extinction by pairing 
a learned CS to a new US (instead of presenting the CS unpaired). This new US can 
be both aversive or appetitive. It has been shown that aversive counter-conditioning 
can effectively reduce reinstatement of cocaine seeking in rats (Tunstall et al., 2012). 
However, the role of individual differences and the role of cocaine taking history remains 
unknown. In short, while extensive research has gone into increasing extinction or 
extinction consolidation to prevent relapse, either by pharmacological and/or behavioral 
methods, so far no adequate treatment enhancement has been found (Chesworth and 
Corbit, 2015). This underlines the need for more research into the treatment of cocaine 
addiction, especially in vulnerable individuals. 
Role of 5-HT system in drug addiction
As discussed above, 5-HT is one of the monoamines that is increased in the extracellular 
space by cocaine administration. It was discovered in 1953, and is derived from the 
essential amino acid tryptophan. It is present in the gastrointestinal tract, blood platelets 
and the central nervous system (CNS). In the CNS, serotonin regulates a wide variety 
of bodily functions including regulation of appetite, cognition, mood and sleep. In order 
to fulfill this myriad of functions the serotonergic system includes a wide variety of 5-HT 
receptors, forming a complex system that is currently not fully understood despite over 
60 years of research. In contrast to this, a single protein, the serotonin transporter (5-
HTT), is responsible for the reuptake of 5-HT after signal transduction. Because of its 
many functions, it logically follows that an alteration in the homeostasis of 5-HT has been 
linked to many neurological disorders such as major depressive disorder, anxiety related 
disorders, aggressive disorders and addiction (Olivier, 2015).Ch
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Repeated exposure to cocaine will lower baseline tissue 5-HT levels (Parsons et al., 1995) 
which is paired to an increase in withdrawal related symptoms. In addition, it has been 
shown that several of the 5-HT receptors undergo adaptive changes, leading to hypo 
sensitive 5-HT1A and 5-HT1B auto-receptors as well as the post-synaptic hyposensitive 
5-HT2C and 5-HT3 receptors and hypersensitive 5-HT2A receptors. These pre- and post-
synaptic changes are thought to contribute to drug-use associated behaviors (Muller and 
Homberg, 2015). 
5-HTT and the vulnerability to develop drug addiction
In the human population, a polymorphism exists in the promoter region of the 5-HTT 
gene (5-HTTLPR). The 5-HTTLPR consists of a GC-rich 20-23 base-pair long repeating 
sequence that, for the most part, creates a short (14 repeats, s-allele) or a long version 
(16 repeats, l-allele, see figure 1), although some other variants are possible (Lesch et 
al., 1996; Nakamura et al., 2000). The s-allele is associated with lower transcriptional 
efficiency and therefore it is hypothesized that carriers of the s-allele have lower expression 
of the 5-HTT protein and higher concentrations of 5-HT in the synaptic cleft (Heils et al., 
1996). The 5-HTTLPR has been thoroughly investigated in the last few decades and is 
associated with a variety of neurological disorders including major depressive disorder 
(Bleys et al., 2018; Caspi et al., 2003), anxiety disorders (Stein et al., 2008) and, most 
important for this thesis, several different kinds of addictive disorders (Cao et al., 2013; 
Enoch et al., 2011; Feinn et al., 2005; Gerra et al., 2007; Gokturk et al., 2008; Martin-
Santos et al., 2010).
Short
Long
Lifelong low 5-HTT availability
Lifelong high 5-HTT availability
Increased risk of addiction
Human Chr. 17 5-HTT gene Promotor region
Figure 1. 5-HTTLPR in the human population. In humans, the 5-HTT gene is located on chromosome 17. The 
short version of the polymorphism, which is located in the promoter region of the gene, is associated with reduced 
transcriptional efficiency and therefore lower 5-HTT availability. Carriers of the s-allele have an increased chance 
of developing several kinds of neurological disorders, including addiction (Heils et al., 1996; Lesch et al., 1996).
Animal models allow the study of 5-HTT under controlled circumstances and are crucial 
to our understanding of the behavioral and biochemical consequences of genetic 5-HTT 
downregulation. In 1998, Bengel and colleagues were the first to produce serotonin 
transporter knockout (5-HTT-/-) mice (Bengel et al., 1998). This animal model has since 
shown to mimic the s-allele of the 5-HTTLPR, with increased symptoms of anxiety and 
depression (Holmes et al., 2003a; Holmes et al., 2002; Lira et al., 2003) and increased 
cocaine induced conditioned place preference (CPP) (Sora et al., 1998) but not cocaine 
self-administration (Thomsen et al., 2009). The creation of the 5-HTT-/- rat in 2006, by 
ENU induced mutagenesis, allowed for a more detailed study of 5-HTT knockdown on 
addiction, pharmacology and complex cognitive tasks (Homberg et al., 2008; Smits et al., 
2006). This model has been researched extensively in the past decade and is thought, 
like the 5-HTT-/- mouse, to model the s-allele of the 5-HTTLPR. Indeed, compared to 
wild-type (5-HTT+/+) controls, 5-HTT-/- rats show increased anxiety and depression related 
symptoms (Homberg et al., 2007; Olivier et al., 2008). More importantly for this thesis, 
they show increased susceptibility to cocaine. For instance, these rats show increased 
cocaine induced locomotor behavior and cocaine induced conditioned place preference 
(CPP) (Homberg et al., 2008) as well as increased short- and long-access cocaine self-
administration (Homberg et al., 2008; Verheij et al., 2017), which are thought to measure 
recreational and compulsive drug taking, respectively (Ahmed and Koob, 1998). In 
addition, after cocaine self-administration, the motivation to take cocaine, as measured 
under a progressive ratio of responding, is also increased in 5-HTT-/- rats (Homberg et 
al., 2008; Verheij et al., 2017). 
In light of the different mechanisms that may underlie the susceptibility to cocaine 
discussed above, there is currently evidence that an increase in NES may contribute 
to this increase in cocaine self-administration. 5-HTT-/- rats showed a decrease of CRF 
immunodensity in the CeA and the paraventricular nucleus of the hypothalamus, which 
is hypothesized to indicate an increase in the release of CRF in these areas following 
long-access to cocaine self-administration. Decreased CRF immunodensity in these 
areas is in turn correlated to an increase in anxiety like behavior (NES) as measured in 
the elevated plus maze (EPM) (Verheij et al., 2017). In addition, the attention of s-allele 
carrying humans is increased towards both negative (Pergamin-Hight et al., 2012) and 
positive (Fox et al., 2011) CSs, and behavior of the 5-HTT-/- rat is strongly driven by 
Pavlovian CSs (Nonkes and Homberg, 2013) suggesting 5-HTT-/- rats may have stronger 
CS driven cocaine seeking. In addition, the extinction of fear and drug-related conditioned 
responses to these CSs is decreased in 5-HTT-/- rats (Homberg et al., 2008; Nonkes et 
al., 2012a; Schipper et al., 2011). In line with this, it has been shown that 5-HTT-/- rodents 
exhibit lower vmPFC and higher amygdala activation during fear extinction recall (Pang 
et al., 2011) and display glutamatergic pyramidal neuron morphological changes in the 
same areas (Wellman et al., 2007). These findings imply that changes in the glutamatergic 
system may be at the core of decreased 5-HTT-/- extinction deficiency. 
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Thesis aim and outline
As outlined above, there is converging evidence that 5-HTT down-regulation predisposes 
a person to develop addictive behavior. In addition, in rats, once addiction is established 
5-HTT gene down-regulation makes it harder to treat with conventional methods. However, 
5-HTT5-HTT-/-  rats have also shown increased cognitive flexibility. When subjected to 
a reversal learning paradigm, 5-HTT-/- rats switch contingencies faster than 5-HTT+/+ 
controls, even after cocaine self-administration (Nonkes et al., 2013). Additionally, fear 
extinction was increased compared to 5-HTT+/+ rats when also presented with a cue 
predicting food delivery (Nonkes et al., 2012a). In concordance with the ‘for-better-or-
worse’ concept for gene x environment interactions (Belsky et al., 2009), this may - on 
the one hand - provide a potential cause of increased addiction sensitivity, and - on the 
other hand - an opportunity for treatment (Homberg and Lesch, 2011). This thesis sets 
out to try and investigate these two sides of the same coin. 
To this end, in chapter 2, we present the results of ultra-high resolution structural 
MRI study in which we investigate the structural integrity of brain areas involved in 
the addiction network. An earlier study (van der Marel et al., 2013) showed almost no 
structural differences between the genotypes after a single injection of cocaine. In the 
study described in chapter 2 we compare naïve 5-HTT+/+ and 5-HTT-/- rats and rats that 
underwent long-access to cocaine or sucrose self-administration. Our region of interest 
(ROI)-based analysis includes brain areas that show structural or functional differences 
in s-allele carrying humans and/or are involved in Pavlovian learning, extinction, and 
addiction. We found several differences in brain anatomy, including the volumes of DRN 
and the amygdala which were altered in the 5-HTT knockout rats after self-administration. 
As discussed above, at molecular level, cocaine is able to increase extracellular levels 
of DA, NA and 5-HT. It has also been suggested that the differences in psychostimulant 
intake of 5-HTT-/- rats is caused by differences in other monoamine systems (i.e. NA 
and DA) (Oakly et al., 2014). Therefore, in chapter 3, we used in vivo microdialysis in 
5-HTT+/+ and 5-HTT-/- rats to collect extracellular fluid after saline or cocaine exposure. 
The extracellular levels of 5-HT, DA and NA were then determined using high performance 
liquid chromatography (HPLC). We show that, upon a single injection of cocaine, there is 
no difference in accumbal or hippocampal DA and NA release between 5-HTT genotypes, 
indicating that these neurotransmitters probably don’t play a major role in the 5-HTT-/- 
rat drug taking phenotype. In contrast to this, baseline 5-HT was greatly increased in 
5-HTT-/- rats, while cocaine-induced release of 5-HT was greatly blunted. 
As discussed above, the 5-HTT-/- rat has shown a decrease in extinction based learning. 
In chapter 4, we set out to try to increase extinction consolidation of cocaine-induced CPP 
by stimulating the glutamatergic signaling just after extinction learning by intravenous 
administering the D-Cycloserine (DCS). However, in line with the NMDA receptor mRNA 
levels, 5-HTT-/- rats were less sensitive to DCS treatment, requiring a higher dose to 
achieve significant reduction of cocaine seeking.
In contrast to extinction learning, the 5-HTT-/- rat has increased cognitive flexibility 
and is able to adjust behavior faster than 5-HTT+/+ controls when there is a switch in 
valence of the cues. In chapter 5, we try to capitalize on this cognitive flexibility by 
developing, as an alternative behavioral treatment, a touch-screen based counter-
conditioning paradigm. During acquisition of self-administration, two visual stimuli are 
paired to sucrose or cocaine-self administration. Subsequently, one cue is paired to a 
mild footshock (counter-conditioning) while the other is paired to nothing (conventional 
extinction training). We then test if drug-induced reinstatement occurs to both stimuli. 
While the paradigm was able to outperform typical extinction training in 5-HTT+/+ rats, 
which is in line with previously published results, 5-HTT-/- rats did not seem to benefit from 
this behavioral approach. 
In chapter 6 these results are all discussed and placed in a broader context. 
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ChapterUltra-high resolution 
structural MRI reveals 
structural brain differences 
in serotonin transporter 
knockout rats before and 
after cocaine or sucrose 
self-administration
“Long intensive physical work is performed without any fatigue...This result is enjoyed 
without any of the unpleasant after-effects that follow exhilaration brought about by 
alcohol....Absolutely no craving for the further use of cocaine appears after the first, or 
even after repeated taking of the drug...” 
Sigmund Freud (Über coca)
Peter Karel, Annette van der Toorn, Liesbeth Reneman, 
Louk J.M.J. Vanderschuren, Rick M. Dijkhuizen, 
Michel M.M. Verheij, Judith R. Homberg
Manuscript in preparation
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Abstract 
Excessive use of cocaine is known to cause neurotoxicity and to induce changes in 
brain white and gray matter. Lower expression of the serotonin transporter (5-HTT) is 
associated with a risk to develop cocaine dependence. A previous study, using 5-HTT 
knockout (5-HTT-/-) rats, has shown a relationship between brain structure, 5-HTT 
genotype and susceptibility to cocaine addiction. Here we expand these findings by using 
ultra-high resolution structural MRI on post-mortem tissue of naïve 5-HTT+/+ and 5-HTT-/-
 rats, and rats that underwent long access to cocaine or sucrose self-administration. 
In naïve 5-HTT-/- rats, compared to 5-HTT+/+ rats, ultra-high resolution structural MRI 
revealed a lower mean diffusivity (MD) in the orbital frontal cortex, medial prefrontal 
cortex and nucleus accumbens. 5-HTT-/- rats self-administered more cocaine, but not 
sucrose under long access conditions. After a history of either sucrose or cocaine self-
administration, 5-HTT-/- rats had a smaller amygdala. Moreover, we found an interaction 
between genotype and type of reward for dorsal raphe nucleus volume, which correlated 
with motivation to self-administer cocaine but not sucrose. These findings may partially 
explain the 5-HTT-/- drug taking phenotype, as the DRN is central to the reward circuitry.
Introduction
Cocaine use remains a pressing health and societal concern. According to the “European 
Drug Report 2017” of the European Monitoring Centre for Drugs and Drug Addiction, 
17.5 million Europeans (5.2%) have taken cocaine in their lifetime, making it the second 
most used illicit drug of abuse in Europe after cannabis (EMCDDA, 2017). In humans, 
heavy cocaine use is known to cause severe neurotoxicity (Pereira et al., 2015) and can 
lead to changes in brain gray (Hall et al., 2015; Ide et al., 2014) and white matter (Lim et 
al., 2002; Moeller et al., 2005). 
Serotonin (5-HT) is a neurotransmitter that serves many physiological functions and 
dysregulation of 5-HT is linked to a variety of neuropsychiatric disorders including anxiety 
and depression (Bleys et al., 2018; Caspi et al., 2003; Lesch et al., 1996). Carriers of 
the short (s)-allele of the serotonin transporter (5-HTT) linked polymorphic region 
(5-HTTLPR) exhibit lower levels of serotonin transporter mRNA transcription and these 
subjects are hypothesized to have higher levels of extracellular brain 5-HT (Heils et al., 
1996). In addition to anxiety and depression, carrying the s-allele of the 5-HTTLPR is 
associated with an increased risk for addictive disorders (Cao et al., 2013; Feinn et al., 
2005; Gokturk et al., 2008). 5-HTT knockout (5-HTT-/-) rats mimic these behaviors and 
are often used to model the 5-HTTLPR polymorphism. Of particular interest for this study, 
5-HTT knockout rats show higher baseline levels of extracellular brain 5-HT (Verheij et 
al., 2014) increased levels of anxiety- and depression-like behavior (Homberg et al., 
2007; Verheij et al., 2017), enhanced cocaine induced conditioned place preference 
(CPP) and, most importantly, increased intravenous cocaine self-administration under 
both short (Homberg et al., 2008) and long access conditions (Verheij et al., 2017), which 
model moderate and compulsive drug taking, respectively (Ahmed and Koob, 1998).
Various structural and functional MRI studies have been performed to reveal brain regions 
contributing to the increased risk of s-allele carriers to develop psychiatric conditions. 
Some of these studies showed smaller grey matter volumes in the amygdala (Frodl et 
al., 2008; Kobiella et al., 2011; Pezawas et al., 2005), hippocampus (Eker et al., 2011; 
Frodl et al., 2008; Little et al., 2014), orbital frontal cortex (Atmaca et al., 2011; Little et al., 
2014), anterior cingulate cortex (Canli et al., 2005; Selvaraj et al., 2011) and insula (Igata et 
al., 2017) of s-allele carriers compared to homozygous long (l)-allele carriers. Additionally, 
reduced fractional anisotropy (FA), pointing towards reduced fiber density, reduced 
axonal diameter or reduced myelination (Alexander et al., 2011), has been observed in 
the uncinate fasciculus (Pacheco et al., 2009) of healthy s-allele carriers. In addition, using 
functional MRI, s-allele carriers show hyperactivity of the amygdala (Canli et al., 2005; 
Gillihan et al., 2010; Klucken et al., 2013; Kobiella et al., 2011; Madsen et al., 2016), insula 
(Klumpp et al., 2014), orbital frontal cortex and nucleus accumbens (Klucken et al., 2013). 
Interestingly, many of these brain regions that differ between s- and l-allele carriers overlap Ch
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with addiction circuitries, suggesting that some of the brain regions mentioned above may 
regulate increased drug intake in s-allele carriers (Hyman et al., 2006). 
In contrast to human imaging studies, so far only one animal imaging study has directly 
investigated the relationship between low 5-HTT expression, structural brain connectivity, 
and susceptibility to cocaine. In this study using functional MRI and structural DTI, Van 
der Marel and colleagues found no differences between 5-HTT-/- and 5-HTT+/+ rats after 
a single injection of cocaine, with the exception of reduced FA values in the genu of the 
corpus callosum of 5-HTT-/- rats (van der Marel et al., 2013). However, it remains unknown 
whether and how 5-HTT affects structural changes in the brain after extended cocaine 
self-administration. We hypothesize that structural differences between 5-HTT+/+ and 
5-HTT-/- rats are more subtle than could be detected in the Van der Marel study above. 
Therefore, in this study, we have used ultra-high resolution (75 µm isotropic voxels) 
structural MRI on post-mortem fixed brain tissue of drug naïve 5-HTT-/- and 5-HTT+/+ 
rats, as well as 5-HTT-/- and 5-HTT+/+ rats after extended access to cocaine, or sucrose 
self-administration. This way we achieved a higher resolution compared to what can be 
obtained using in vivo imaging. 
Materials and Methods 
Animals
Male 5-HTT+/+ and 5-HTT-/- rats were generated through heterozygous breeding. All rats were 
housed in Macrolon cages measuring 40 x 25 x 18 cm (l x w x h) in climate controlled rooms 
at 21 ±1°C and 55 ±15% relative humidity. Rats that underwent behavioral experiments were 
housed under a reversed 12 hours day-night cycle (lights on at 19:00). Food (SDS chow) 
and water were available ad libitum except when animals were in experiment. Animals were 
divided in three groups: naïve, cocaine or sucrose self-administration. All animal experiments 
were approved by the Animal Ethics Committee of the Utrecht University and all efforts were 
made to diminish animal suffering and to reduce the number of rats used. 
Surgery 
Rats (PND 90-120) that received cocaine or sucrose self-administration were anesthetized 
using 0.8 ml/kg i.m. Hypnorm (0.315 mg/ml fentanyl citrate, 10 mg/ml fluanisone, VetaPhar-
ma Ltd.) and 0.5 ml/kg i.p. Dormicum (1 mg/ml midazolam, Roche). Rats were then implan-
ted with a single catheter (Camcaths) consisting of a 22 g stainless steel canula attached to a 
nylon mesh and silastic tubing with a 0.30 mm internal diameter. The catheter was placed in 
the right jugular vein and aimed towards the superior vena cava. The mesh at the end of the 
catheter was sutured under the skin of the dorsum. Rimadyl (50 mg/kg, Pfizer) and Gentami-
cin (50 mg/kg) were administered s.c. 15 min prior and 24 and 48 hours after surgery. Starting 
two days after surgery catheters were flushed daily with 0.3 ml sterile saline containing Hepa-
rin (50 IU/ml, LEO Pharma) and Gentamicin (10 mg/ml, Life Technologies) (Gao et al., 2017).
Apparatus
Self-administration experiments were conducted in operant conditioning chambers 
measuring 29.5 x 24 x 25 cm, l x w x h (Med Associates). The floor of the boxes consisted 
of stainless steel rods over an aluminum waste pan, the left and right walls consisted of 
aluminum and the back wall, top and door at the front consisted of clear polycarbonate. 
The boxes were placed in sound attenuating cubicles which were equipped with a 
ventilation fan that produced a constant background noise. Two 4.8 cm wide retractable 
levers were placed on the right wall placed 11.7 cm apart and 6.0 cm from the grid floor. 
Positioned above each lever there was a cue light (28V, 100 mA), and a house light (28V, 
100 mA) in the top far corner on the opposite wall. The food cup, for delivering sucrose 
pellets, was located on the right wall between the levers. Cocaine delivery was controlled 
by a syringe pump, and was delivered to the rat via polyethylene tubing that ran from 
the syringe pump through a swivel and a metal spring to a screw cap that could be 
connected to the cannula on the rats back. The experiment was controlled and recorded 
by MedState Notation using MED-PC for Windows (Gao et al., 2017).
Experimental procedures
Extended access cocaine and sucrose self-administration
Rats that underwent cocaine or sucrose self-administration were placed in the 
administration boxes and connected to the syringe pump. The session started when 
both the levers extended into the box and the house light turned on. During the session 
responding to the correct lever (CL), which was counterbalanced across animals, 
resulted in a reward consisting of either a 45 mg sucrose pellet or a 0.5 mg/kg cocaine 
hydrochloride infusion (volume 0.1 mg/kg), depending on the experimental group on a 
FR1 schedule (Verheij et al., 2017). Reward delivery was reinforced by illumination of 
the cue light for 30 seconds following reward. During this period, responding to the CL 
did not result in additional rewards, but was recorded as a correct response. Responding 
to the incorrect (ICL) lever was recorded but had no programmed consequences. To 
prevent overdose, the maximum amount of rewards was set to 25 for the first 3 days of 
administration, 30 for the next 2 days, 50 for administration day 6 and 150 for the rest of 
the experiment. If the maximum amount of rewards was met, both levers would retract 
which would prohibit the rats from responding further. Rats were placed in the box 5 days 
a week for 6 hours a day, according to the long access model of compulsive cocaine 
taking (Ahmed and Koob, 1998). On the 19th day of testing, rats underwent a progressive 
ratio (PR) schedule of reinforcement to measure motivation to take cocaine or sucrose 
(Hodos, 1961). During PR the number of CL presses to receive reward increases 
exponentially according to the following equation: required CL presses = (5 x e(injection number 
x 0.2)) – 5 (Richardson and Roberts, 1996). If rats did not reach the criterion for the next 
reward within 30 minutes, both levers retract and the protocol would terminate. On day Ch
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20 of testing, rats were switched back to a FR1 schedule of responding for 6 hours. In 
total 20 5-HTT+/+ and 15 5-HTT-/- rats completed this behavioral paradigm 
Transcardial perfusion and tissue preparation
Self-administration animals were anesthetized 24 hours after self-administration day 20 
using 120 mg/kg pentobarbital (AST pharma) and transcardially perfused using 0.1M PBS 
(pH = 7.3) followed by 4% paraformaldehyde (PFA, Sigma-Aldrich, pH = 7.2). Heads were 
post-fixed in 4% PFA overnight at 4 °C and stored in PBS at 4 °C. The perfusion-fixed 
brains were inserted in a custom-made holder and immersed in non-magnetic and MR 
invisible oil (Fomblin, Solvay Solexis) for MR experiments. Naïve animals were sacrificed 
in a similar manner at similar ages but without any other experimental manipulations. 
Ultra-high resolution structural MRI
Structural MRI was performed using a 9.4 T horizontal bore MR system (Varian, Palo 
Alto, CA, USA) equipped with a 6 cm ID gradient insert with gradients up to 1 T/m. A 
custom-made solenoid coil with an internal diameter of 2.6 cm was used for excitation 
and reception of the MR signal. Diffusion tensor imaging was performed using a 3D 
diffusion-weighted spin-echo sequence with an isotropic spatial resolution of 150 µm. 
The read- and phase- encode direction were acquired using 8-shot EPI encoding and the 
second phase direction was linearly phase-encoded (TR/TE 500/32.4 ms, 220*128*108 
matrix, FOV 33*19.2*16 mm3, Δ/δ 15/4 ms, b 3842 s/mm2, 60 diffusion-weighted images 
in non-collinear directions and 4 images without diffusion weighting (b=0), number of 
averages 1, total number of images 64). Subsequently, four 3D BSSFP images were 
acquired with an isotropic spatial resolution of 75 µm (TR/TE 15.4/7.7 ms, flip angle 40°, 
426*214*256 matrix, FOV 32*16*19 mm3, 12 averages, pulse angle shift 0°, 90°, 180° 
and 270°). The four images were added as complex images to obtain a single BSSFP 
image with reduced banding artifacts in the brain, which is referred to as an anatomical 
MR image. Total acquisition time per brain was 11 hours and 15 minutes.
Morphometric analysis
Anatomical MR images were used to obtain brain masks using a brain extraction tool 
(BET2) as implemented in the FMRIB Software Library (FSL) (Jenkinson et al., 2012). 
The brain-extracted images were subsequently linearly registered to one of the brain 
images from the control group using FSL’s linear registration tool FLIRT (Jenkinson et 
al., 2002; Jenkinson and Smith, 2001) followed by the non-rigid registration tool (FNIRT). 
A template image was generated by non-rigid registration of the images of the control 
group to a starting template (one representative image of the control group) followed by 
averaging all the transformed images to the final template. 
Regions of Interest (ROIs) were defined on the template anatomical image guided by the 
rat brain atlas from Paxinos and Watson (Paxinos and Watson, 2006). ROIs were selected 
based on the literature discussed in the introduction and included: amygdala (Amy), 
hippocampus (Hip), orbital frontal cortex (OFC), medial prefrontal cortex (mPFC), anterior 
cingulate cortex (ACC), insular cortex, caudate putamen (CPU), nucleus accumbens (NAc), 
dorsal raphe nucleus (DRN) and corpus callosum (CC). These ROIs were registered to the 
individual rat brain images and their sizes in the individual images were obtained. 
Segmentation of grey matter, white matter and CSF in the ROIs was accomplished through 
thresholding. In the anatomical images thresholding was based on signal intensity. All 
anatomical images were normalized by setting the median signal intensity of the motor 
cortex to 1. Subsequently, tissue signal intensities lower than 0.85, between 0.85 and 1.35, 
and higher than 1.35 were defined as grey matter, white matter and CSF, respectively.
For DTI data, white matter was defined as tissue with FA above 0.25 and MD below or 
equal to 0.34 ´ 10-9 mm2/s. Grey matter was defined as tissue with FA below or equal to 
0.25 and MD below or equal to 0.34 ´ 10-9 mm2/s. CSF was defined as tissue with FA 
below or equal to 0.25 and MD above 0.34 ´ 10-9 mm2/s.
Statistics
All statistical analyses were performed by using IBM SPSS version 24 (IBM software). 
Day-to-day consumption of cocaine/sucrose was analyzed using a genotype (2 levels) 
x session (19 levels) repeated measures ANOVA, while total rewards consumed and 
progressive ratio breakpoint were analyzed using independent t-tests. All MRI variables 
were analyzed using multivariate ANOVAs using the Benjamini-Hochberg correction 
for multiple testing on all acquired p-values (Hochberg and Benjamini, 1990). Note that 
naïve and drug self-administration rats were analyzed separately because of differences 
in housing, surgery and time of post-mortem storage of brain tissue prior to scanning. 
Relationships between significant interactions found in the behavioral group and 
behavioral parameters were examined using Pearson correlation analysis.
Results
Behavior
Figure 1 shows sucrose and cocaine taking behavior across sessions. In the sucrose 
cohort (figure 1A, C and E), no significant genotype differences in self-administration 
over sessions, or progressive ratio performance were observed (self-administration (fi-
gure 1A): F(18,288) = 1.426, p = NS; PR (figure 1E): t(17) = 0.101, p = NS). However, when 
all the rewards received during the 19 self-administration sessions were pooled, 5-HTT-
/- animals consumed slightly less sucrose pellets compared to their 5-HTT+/+ counter-
parts (Figure 1C: t(10.645) = -2.922, p<0.05). In contrast to these findings, in the cocaine 
cohort, 5-HTT-/- rats self-administered more cocaine over sessions (figure 1B: F(18, 288) = C
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2.164, p<0.01) and received more cocaine throughout the whole experiment compared 
to 5-HTT+/+ rats (figure 1D: t(11.746) = 3.271, p<0.01). Additionally, the 5-HTT
-/- rats were also 
more motivated to take cocaine as measured by a progressive ratio schedule of reinfor-
cement (figure 1F: t(14.283) = 2.212, p<0.05). 
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Figure 1. Cocaine and sucrose self-administration of 5-HTT-/- versus 5-HTT+/+ rats. All data are represented 
as mean ± SEM. White symbols and bars represent 5-HTT+/+ rats while black symbols and bars represent 5-HTT-
/- rats. G*T indicates a significant interaction using a repeated measures ANOVA, *p<0.05 (versus 5-HTT+/+, 
independent samples t-test). No difference between groups is observed in day-to-day sucrose self-administration 
(A) or motivation to self-administer sucrose (E). However, cumulative intake of sucrose (C) is significantly lower 
in 5-HTT-/- rats. In contrast to this, when self-administering cocaine, 5-HTT-/- rats administered more cocaine on a 
day-to-day basis (B), had higher cumulative intake (D) and show increased motivation to administer cocaine (F). 
20 5-HTT+/+ and 15 5-HTT-/- rats completed this behavioral paradigm. 
Structural MRI analysis 
Naive animals
Structural analysis of Grey matter, white matter and CSF 
Grey matter (GM), white matter (WM) and CSF volume, mean diffusivity (MD) and 
fractional anisotropy (FA) values for naïve 5-HTT+/+ and 5-HTT-/- rats are displayed in 
table 1. After Benjamini-Hochberg correction, no significant differences in the values 
were observed between the 2 genotypes. 
Table 1. WM, GM and CSF volume, MD and FA of naïve 5-HTT+/+ and 5-HTT-/- rats. Significant changes before 
correction for multiple testing (#) are highlighted. GM: grey matter, WM: white matter, CSF: cerebral spinal fluid
.
5-HTT+/+ 5-HTT-/- Statistics
Average SEM Average SEM F p
Effect 
size (ηp
2)
Volume 
(µl)$
GM 944.336 12.329 947.335 11.780 0.031 0.862 0.001
WM 407.593 11.214 407.014 6.210 0.002 0.964 0.000
CSF 78.979 7.494 71.010 6.650 0.637 0.434 0.029
MD&
GM 0.273 0.002 0.269 0.003 1.083 0.310 0.049
WM 0.267 0.003 0.257 0.004 4.086 0.056 0.163
CSF 0.566 0.010 0.601 0.011 5.321# 0.031# 0.202#
FA &
GM 0.178 0.001 0.179 0.001 0.367 0.551 0.017
WM 0.390 0.001 0.388 0.001 0.741 0.399 0.034
CSF 0.136 0.001 0.133 0.002 1.742 0.201 0.077
Structural analysis of the predefined ROIs
Volume, MD and FA values of the 10 predefined ROIs of naïve 5-HTT+/+ and 5-HTT-/- rats 
are displayed in table 2. ANOVA analysis followed by Benjamini-Hochberg correction, 
revealed lower MD in OFC, mPFC and NAc in 5-HTT-/- compared to 5-HTT+/+ rats (Figure 
2: OFC: F(1,21) = 13.684, p<0.001; mPFC: F(1,21) = 7.489, p<0.05; NAc: F(1,21) = 8.054, 
p<0.01) ). Additionally, when not correcting for multiple testing, significantly larger NAc 
volume, lower MD in CPU, Amy, DRN and Insular, and lower FA in the NAc, Amy and 
insular of 5-HTT-/- compared to 5-HTT+/+ rats were observed (for statistics see table 2). 
$Data acquired from anatomical data
&Data acquired from DTI data
# Effect significant without correction for multiple testing
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Table 2. ROI volume, MD and FA of naïve 5-HTT+/+ and 5-HTT-/- rats. Significant changes before correction for 
multiple testing (#) and after Benjamini-Hochberg correction (*) are highlighted. OFC: orbitofrontal cortex, mPFC: 
medial prefrontal cortex, ACC: anterior cingulate cortex, CPU: caudate putamen, Hip: hippocampus, NAc: 
nucleus accumbens, AMY: amygdala, DRN: dorsal raphe nucleus, Insular: insular cortex, CC: corpus callosum. 
5-HTT+/+ 5-HTT-/- Statistics
Average SEM Average SEM F p
Effect 
size (ηp
2)
Volume (µl)$
OFC 25.668 0.619 26.186 0.410 0.504 0.486 0.023
mPFC 11.430 0.220 12.200 0.390 2.775 0.111 0.117
ACC 19.228 0.429 19.525 0.313 0.321 0.577 0.015
CPU 76.540 1.590 78.020 1.040 0.628 0.437 0.029
HiP 93.051 1.559 92.141 1.163 0.224 0.641 0.011
NAc 14.650 0.410 15.710 0.230 #5.288 #0.032 #0.201
AMY 24.741 0.553 24.531 0.405 0.096 0.759 0.005
DRN 0.960 0.040 0.920 0.030 0.696 0.413 0.032
Insular 43.388 1.463 45.142 0.755 1.194 0.287 0.054
CC 33.080 0.790 32.470 0.760 0.311 0.583 0.015
MD&
OFC 2.90E-04 3.05E-06 2.77E-04 3.49E-06 *13.684 *0.001 *0.395
mPFC 2.89E-04 3.37E-06 2.74E-04 4.37E-06 *7.489 *0.012 *0.263
ACC 2.87E-04 2.31E-06 2.79E-04 3.51E-06 #3.210 #0.088 #0.133
CPU 2.83E-04 1.62E-06 2.75E-04 2.66E-06 #5.906 #0.024 #0.219
HiP 3.00E-04 1.44E-06 2.95E-04 2.20E-06 4.138 0.055 0.165
NAc 2.87E-04 2.06E-06 2.76E-04 3.24E-06 *8.054 *0.010 *0.277
AMY 3.00E-04 2.80E-06 2.86E-04 4.89E-06 #5.302 #0.032 #0.202
DRN 2.87E-04 2.28E-06 2.77E-04 3.74E-06 #5.568 #0.028 #0.21 0
Insular 2.97E-04 3.41E-06 2.86E-04 3.58E-06 #4.925 #0.038 #0.190
CC 2.25E-04 3.12E-06 2.16E-04 4.96E-06 2.521 0.127 0.107
FA&
OFC 0.236 0.003 0.224 0.004 4.300 0.051 0.170
mPFC 0.243 0.002 0.232 0.005 3.363 0.081 0.138
ACC 0.245 0.003 0.236 0.005 1.855 0.188 0.081
CPU 0.216 0.004 0.208 0.004 2.011 0.171 0.087
HiP 0.239 0.002 0.236 0.002 1.279 0.271 0.0570
NAc 0.281 0.004 0.261 0.006 #7.781 #0.011 #0.270
AMY 0.266 0.005 0.250 0.005 #4.849 #0.039 #0.188
DRN 0.228 0.005 0.205 0.010 3.585 0.072 0.146
Insular 0.218 0.002 0.207 0.003 #6.376 #0.020 #0.233
CC 0.610 0.004 0.595 0.009 2.264 0.147 0.097
$
Data acquired from anatomical data
&
Data acquired from DTI data
# 
Effect significant without correction for multiple testing
*Effect significant after Benjamini-Hochberg correction
Figure 2. Significant reduction of mean 
diffusivity (MD) in naïve 5-HTT-/- rats. 
All data are represented as mean ± SEM. 
White and black bars represent 5-HTT+/+ 
and 5-HTT-/- rats, respectively. In naïve 
5-HTT-/- rats MD was significantly reduced 
in the OFC, mPFC and NAC. mPFC: medial 
prefrontal cortex, NAc: nucleus accumbens, 
OFC: orbitofrontal cortex.
Sucrose and cocaine self-administration animals
Structural analysis of grey matter, white matter and CSF 
GM, WM and CSF volume, MD and FA values for 5-HTT+/+ and 5-HTT-/- rats after sucrose 
or cocaine self-administration are displayed in table 3. A genotype effect was observed 
for CSF and WM volume (WM: Figure 3A: F(1,31) = 4.962, p<0.05; CSF: Figure 3B: F(1,31) = 
5.481, p<0.05). Independent samples t-test post-hoc analysis revealed that this genotype 
effect in the WM was caused by a significant reduction of WM volume in the 5-HTT-
/- rats in the sucrose, but not the cocaine cohort (t(15) = -2.780, p<0.05). However, post-
hoc analysis of the CSF volume failed to reach statistical significance in either cohort, 
although a trend towards significantly smaller CSF volume was observed in 5-HTT-/- rats 
of the sucrose group (sucrose: t(11.829) = -1.970, p = 0.073; cocaine: t(16) = 1.349, p = NS). 
Additionally, when not correcting for multiple testing, a significant genotype x treatment 
interaction was observed for WM volume (for statistics see table 3). 
Figure 3. Altered WM and CSF volume in 5-HTT+/+ and 
5-HTT-/- rats that underwent sucrose or cocaine self-
administration. All data are represented as mean ± SEM. 
White and black bars represent 5-HTT+/+ and 5-HTT-/- rats, 
respectively. A significant genotype effect (G*) was observed 
for the volume of WM (A) and CSF (B). Post-hoc analysis 
revealed the effect of the WM was caused by lower volume 
in 5-HTT-/- rats that self-administered sucrose (*). Post-hoc 
analysis of CSF volume failed to reach statistical significance 
although a trend towards lower volume in 5-HTT-/- that self-
administered sucrose was observed (#). WM: white matter; 
CSF:  cerebrospinal fluid.
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Structural analysis of the predefined ROIs
Volume, MD and FA values of the 10 predefined ROIs for 5-HTT+/+ and 5-HTT-/- rats after 
sucrose or cocaine self-administration are displayed in table 4. Without correction for 
multiple testing, CC volume was smaller in 5-HTT-/- versus 5-HTT+/+ rats and a significant 
treatment effect was observed in the AMY (for statistics see table 4). After Benjamini-
Hochberg correction, 5-HTT-/- rats showed a significantly lower AMY volume (Figure 4A: 
genotype effect: F(1, 31) = 25.911, p<0.001). Post-hoc independent t-testing revealed that 
this effect was significant in both cohorts (sucrose: t(15) = -3.910, p<0.001; cocaine: t(16) 
= -3.241, p<0.01). A significant genotype*treatment interaction was observed for DRN 
volume (Figure 4B: genotype x treatment interaction: F(1, 31) = 11.770, p<0.01). Post-
hoc independent t-test analysis of this effect revealed a significant lower DRN volume 
in 5-HTT-/- rats receiving sucrose compared to 5-HTT+/+ rats of the same cohort (t(15) = 
-3.003, p<0.01) and between 5-HTT+/+ rats receiving sucrose and cocaine (t(18) = 3.597, 
p<0.01). In addition, volume reductions of the DRN, but not AMY, correlated with PR 
responding during the behavioral tests in the cocaine, but not sucrose, cohort (sucrose 
Pearson correlation: 0.334, p = NS (data not shown); cocaine Pearson correlation: 0.470, 
p<0.05, figure 5). 
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Figure 4. Altered AMY and DRN volume in 5-HTT+/+ and 
5-HTT-/- rats that underwent sucrose or cocaine self-
administration. All data are represented as mean ± SEM. 
White bars represent 5-HTT+/+ rats while black bars represent 
5-HTT-/- rats. A significant genotype effect was observed for 
the AMY (A) and a significant interaction of genotype and 
treatment (G*T) was observed for DRN (B). Post-hoc analysis 
revealed the effect of the AMY was caused by lower volume 
in 5-HTT-/- rats from both reward cohorts. Post-hoc analysis 
revealed a lower DRN volume in sucrose receiving 5-HTT-
/- versus sucrose receiving 5-HTT+/+ rats, and in 5-HTT+/+ rats 
receiving cocaine versus 5-HTT+/+ rats receiving sucrose. 
AMY: Amygdala, DRN: Dorsal Raphe Nucleus. 
Figure 5. Correlation between DRN volume and 
motivation to take cocaine. Individual data points are 
shown. White circles represent 5-HTT+/+ rats and black 
squares represent 5-HTT-/- rats. A significant positive relation 
was found between progressive ratio (PR) responding for 
cocaine and DRN volume when pooling all animals. PR: 
progressive ratio, DRN: dorsal raphe nucleus.
Discussion
In this study we analyzed the effect of 5-HTT genetic variation on brain structure 
both under naïve conditions and after exposure to long access cocaine/sucrose self-
administration. In summary, we were able to show several differences in brain area 
structure between 5-HTT-/- and 5-HTT+/+ rats using ultra-high resolution MRI. In naïve rats 
OFC, mPFC and NAc of 5-HTT-/- rats showed lower MD values, while in 5-HTT-/- rats that 
underwent cocaine or sucrose self-administration smaller AMY volume was observed. 
Most interestingly, an interaction between reward type and genotype was observed for 
the volume of the DRN, which also correlated with the motivation to take cocaine but not 
sucrose. 
We first analyzed high resolution structural MRI images of perfused brain tissue of 
naïve 5-HTT+/+ and 5-HTT-/- rats. In line with the results obtained by Van der Marel and 
colleagues previously (van der Marel et al., 2013), few differences were observed 
between genotypes. After correcting for analyzing multiple brain regions, a reduction of 
the MD in the mPFC, NAc and OFC was observed in 5-HTT-/- compared to 5-HTT+/+ rats. 
This may reflect lower cellularity in these areas (Alexander et al., 2011) and is in line 
with OFC structural changes in human s-allele carriers (Atmaca et al., 2011; Little et al., 
2014). Since these animals did not undergo any manipulations it is plausible that these 
changes are caused by innate differences in 5-HTT expression (for review see: Booij et 
al., 2015). Alterations in the top-down control of the mPFC over the NAc may predispose 
5-HTT-/- rats to lose control over cocaine self-administration (for review see: Everitt and 
Robbins, 2005) 
We proceeded to train 5-HTT-/- and wild-type rats to self-administer cocaine or sucrose. 
5-HTT-/- rats self-administered significantly more cocaine throughout the experiment, as 
reflected by higher day-to-day self-administration and an increase in the total amount 
of cocaine infusions taken compared to 5-HTT+/+ rats. Additionally, 5-HTT-/- animals 
were more motivated to take cocaine, as reflected by an increased progressive ratio 
breakpoint. These results are in line with observations by us and others that 5-HTT-/- 
rats are more vulnerable to psychostimulant self-administration (Homberg et al., 2008; 
Oakly et al., 2014; Verheij et al., 2017). In contrast to these findings, self-administration 
of sucrose pellets did not differ between genotypes on a day-to-day basis, and the total 
amount of these pellets consumed was slightly decreased in 5-HTT-/- rats. However, 
no difference in motivation to work for sucrose was observed during the progressive 
ratio schedule of reinforcement. A reduced consumption of sucrose has previously been 
observed in 5-HTT-/- and has been hypothesized to represent anhedonia in this animal 
model (Olivier et al., 2008). Together these data suggest that the observed higher intake 
of cocaine in 5-HTT-/- versus 5-HTT+/+ rats are not driven by genotype differences in 
positive reinforcement. Rather, our findings point to our previously reported notion that 
the genotype differences in long access cocaine intake result from a stronger (withdrawal-
induced) negative emotional state in 5-HTT-/- versus 5-HTT+/+ rats (Verheij et al., 2017). 
On the whole brain level, both WM and CSF (ventricle) volumes tended to be smaller in 
the 5-HTT-/- rats after self-administration, while whole GM volume did not differ between 
genotypes and/or treatments. WM changes have been observed following extended 
exposure to cocaine in animals (Narayana et al., 2014) and humans (Kaag et al., 2017; 
Schlaepfer et al., 2006). As the human studies are generally cross-sectional in nature, 
it is always the question whether these changes in WM are a predisposition to develop 
addictive behavior or due to direct neurotoxicity of the drugs. Animal studies can help 
answer these questions. The present study suggests that the observed differences in WM 
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are due to neurotoxicity, as the naïve rats did not show any differences in these parameters. 
However, a true longitudinal study would be required to fully answer this question. 
When analyzing the 10 predefined ROIs, 5-HTT-/- rats showed smaller AMY volumes, 
independent of sucrose or cocaine self-administration history. As mentioned in the 
introduction, reduced amygdala volume has also been observed in the 5-HTTLPR 
s-allele carriers (Frodl et al., 2008; Kobiella et al., 2011; Pezawas et al., 2005) and 
this may very well contribute to the lower levels of mature and pro-BDNF observed in 
post-mortem punches of the amygdala of 5-HTT-/- versus 5-HTT+/+ rats (Verheij et al., in 
prep.). In addition to this genotype effect on the amygdala, a significant interaction of 
genotype and reward type was found for DRN volume. The DRN was significantly smaller 
in 5-HTT+/+ and 5-HTT-/- rats that underwent long-access cocaine self-administration and 
5-HTT-/- rats that self-administered sucrose, compared to 5-HTT+/+ sucrose animals. This 
not only suggests that long access to cocaine leads to neurotoxicity as discussed above 
(see also: Pereira et al., 2015), but also that the structural changes in response to reward 
can be influenced by individual differences. The DRN, which is the source for most of 
the serotonergic cells in the brain, plays a critical and complex role in reward seeking, 
making these data difficult to interpret (Luo et al., 2016; McDevitt et al., 2014) and is 
hypothesized to contribute to withdrawal-induced negative emotional state in 5-HTT-/- rats 
(Verheij et al., 2017). In line with a smaller DRN, a decrease in the number of serotonergic 
cells in the DRN has been observed in 5-HTT-/- mice (Lira et al., 2003). Additionally, in our 
data, a reduction of DRN volume positively correlated with the motivation to take cocaine, 
but not sucrose, as measured by responding during a progressive ratio of reinforcement. 
Although we cannot draw direct conclusions from the role of the DRN in compulsive drug 
taking from these results, it is tempting to speculate about the underlying mechanisms. 
For example, DRN 5-HT1A auto-receptors, which control cocaine seeking (You et al., 
2016), are reduced in 5-HTT-/- rats (Homberg et al., 2008). Additionally, the release 
of corticotropin-releasing factor (CRF) in the amygdala, which is increased in 5-HTT-
/- rats and rats that have 5-HTT reduced in the DRN at adulthood following long access 
to cocaine (Verheij et al., 2017), plays a critical role during long access cocaine self-
administration (Zorrilla et al., 2012), by inducing a negative emotional state in these rats 
(Verheij et al., 2017). These results, together with the amygdala results discussed above 
may indicate that the DRN and amygdala may work in concert to cause the increased 
cocaine taking of 5-HTT-/- rats.
When comparing the results obtained in this study with the main structural result of Van 
der Marel et al. (2013), we were unable to reproduce the FA changes in genu of the CC. 
However, the Van der Marel study was performed in vivo as opposed to our ex vivo post 
mortem design. Moreover, our ROI included both the genu and the body of the CC which 
may explain this discrepancy. Additionally, a genotype and a reward type x genotype 
interaction effect was obtained for the CC after sucrose and cocaine self-administration, 
but this effect was not significant after correction for multiple testing. Changes in CC 
structure may influence information integration between hemispheres. These results, 
together with the findings that high levels of serotonin during development may influence 
myelination (Fan et al., 2015; Simpson et al., 2011), indicate that the CC, and other major 
WM tracts in general, may warrant further investigation by DTI tractography. 
In conclusion, we show that there are several structural changes in the brains 5-HTT-
/- rats, under naïve conditions and following self-administration, which may contribute 
to the animals’ drug taking phenotype. More detailed analysis of the white matter tracts 
may further contribute to our understanding of increased cocaine self-administration in 
these rats.
Ch
ap
te
r 2
  |
  U
ltr
a-
hi
gh
 re
so
lu
tio
n 
st
ru
ct
ur
al
 M
RI
38 39
ChapterReduced cocaine-
induced serotonin, 
but not dopamine and 
noradrenaline, release in 
rats with a genetic deletion 
of serotonin transporters
“Kid...if you need booze or drugs to enjoy life to the fullest, then you’re doing it wrong” 
Robin Williams
Michel M.M. Verheij, Peter Karel, 
Alexander R. Cools, Judith R. Homberg
European Neuropsychopharmacology. 2014 Nov;24(11):1850-4.
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Abstract
It has recently been proposed that the increased reinforcing properties of cocaine and 
ecstasy observed in rats with a genetic deletion of serotonin transporters are the result 
of a reduction in the psychostimulant-induced release of serotonin. Here we provide the 
neurochemical evidence in favor of this hypothesis and show that changes in synaptic 
levels of dopamine or noradrenaline are not very likely to play an important role in the 
previously reported enhanced psychostimulant intake of these serotonin transporter 
knockout rats. The results may very well explain why human subjects displaying a reduced 
expression of serotonin transporters have an increased risk to develop addiction.
Introduction
Animal studies have shown that a genetic deletion of serotonin transporters (5-HTT) greatly 
enhances the reinforcing properties of cocaine (COC) and ecstasy (MDMA), as well as 
the acquisition of their intake (Homberg et al., 2008; Oakly et al., 2014). These studies 
performed in 5-HTT knockout (5-HTT-/-) rats are in line with human studies showing that a 
reduction in 5-HTT activity predicts an increased psychostimulant intake (Gerra et al., 2007; 
Martin-Santos et al., 2010). Because of the lack of plasmalemmal serotonin transporters 
(Homberg et al., 2007), 5-HTT-/- animals are not only marked by increased extracellular 
levels of serotonin (figure 1a and 2a), but also by a reduced amount of releasable serotonin 
inside their cells (Kalueff et al., 2010). Using 5,7-dihydroxytryptamine-(5,7-DHT)-treated 
rats, it has elegantly been shown that a sustained increase in the baseline extracellular 
central levels of serotonin results in a decreased, instead of an increased, intake of 
psychostimulants (Bradbury et al., 2014). In a recent self-administration study by Oakly et 
al. (2014) it was, therefore, proposed that a reduced evoked release of serotonin underlies 
the observed increased reinforcing properties of COC and MDMA in 5-HTT-/- rats (Oakly et 
al., 2014). Here we provide the missing neurochemical evidence in favor of their hypothesis 
and show that changes in synaptic levels of dopamine or noradrenaline are not likely to play 
an important role in the enhanced psychostimulant intake reported in individuals lacking 
plasmalemmal serotonin transporters.
Materials and methods
5-HTT-/- rats (Slc6a41Hubr) were generated by target-selected ENU-induced mutagenesis 
(for detailed description, see: Homberg et al., 2007). Briefly, high-throughput sequencing 
from mutagenized rats revealed a functional ENU-induced premature stop codon in exon 3 
of the 5-HTT gene of a female Wistar rat. This heterozygous mutant animal was outcrossed 
for at least eight generations to a Wistar background. Homozygous 5-HTT-/- rats were 
generated by crossing heterozygous 5-HTT+/- animals and genotyping was performed at 
the age of 21 days (primer sequences can be found in: (Homberg et al., 2007). All rats were 
individually housed in our standard microdialysis cages (25 x 25 x 35 cm) under controlled 
experimental conditions (12/12h light/dark cycle, 21±1 °C, 60% relative humidity, food 
and water were available ad libitum). Adult male 5-HTT-/-rats and their wild type (5-HTT+/+) 
counterparts were intraperitoneally injected with saline (volume: 1 ml/kg) and cocaine 
(dose: 10 mg/kg) and the synaptic levels of serotonin, dopamine, and noradrenaline 
were measured in the nucleus accumbens shell and the ventral hippocampus according 
to previously described microdialysis procedures (Homberg et al., 2007; Verheij et al., 
2008). The nucleus accumbens and the hippocampus were chosen because they play an 
important role in mediating reward (Carlezon and Thomas, 2009; Devenport et al., 1981). 
Statistics are described in the figure legends. All experiments were in agreement with 
institutional, national, and international laws and guidelines for animal care and welfare.Ch
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Results
COC is known to increase the extracellular monoamine levels by blocking plasmalemmal 
monoamine transporters (Ritz et al., 1987). As expected, the COC-induced serotonin 
increase in both the nucleus accumbens shell and the ventral hippocampus is smaller 
in 5-HTT-/- than 5-HTT+/+ rats (figure 1b and 2b). Despite suggestions that the variation 
in psychostimulant intake between these two rat types is due to (serotonin-induced) 
changes in synaptic dopamine or noradrenaline (Nonkes et al., 2011; Oakly et al., 2014), 
the observed genotype differences in the baseline levels of serotonin (figure 1a and 
2a) were not accompanied by genotype differences in the baseline levels of the two 
other monoamines (dopamine: figure 1c and 2c, noradrenaline: figure 1e and 2e). In 
addition, 5-HTT-/- rats and their 5-HTT+/+ counterparts were found not to differ in both the 
electrically-evoked central release of dopamine and noradrenaline (Homberg et al., 2007) 
as well as the COC-induced increase of the extracellular levels of these two monoamines 
in either the nucleus accumbens (figure 1d and 1f) or the hippocampus (figure 2d and 
2f). Finally, neither the central expression of plasmalemmal dopamine and noradrenaline 
transporters, nor the uptake by these two transporters differs between 5-HTT-/- and 5-HTT+/+ 
rats (Homberg et al., 2007). These data indicate that both the genotype-specific central 
serotonin response to COC (figure 1b and 2b) and the previously reported individual 
differences in the reinforcing effects of this drug (Homberg et al., 2008) are most likely 
not due to (COC-induced) changes in dopaminergic or noradrenergic neurons. Although 
these individual differences in the reinforcing effects between 5-HTT-/- and 5-HTT+/+ rats 
have been found after administration of the same dose of COC that was used in the 
present study (see: Homberg et al., 2008), our study does not fully exclude the possibility 
that COC-induced individual differences in central dopamine and noradrenaline levels 
may potentially contribute to genotype variation in the reinforcing effects between the two 
rat types following the administration of a different dose of the psychostimulant.
Figure 1. Nucleus accumbens 
monoamine levels before and 
after cocaine (COC: 10 mg/kg). 
(a) Increased baseline levels of 
extracellular serotonin (5-HT) in the 
nucleus accumbens shell of 5-HTT-
/- rats (Student’s t-test: *P<0.05). 
(b) Reduction in the COC-induced 
increase of the extracellular 
accumbal serotonin (5-HT) in 
5-HTT-/- rats (ANOVA: time effect: 
P<0.05; genotype x time effect: 
P<0.05, Student’s t-test: *P<0.05). 
(c-f) In spite of a seemingly small 
difference in basal accumbal 
dopamine (DA) and noradrenaline 
(NA) levels, neither these baseline 
monoamine levels nor the COC-
induced increases of accumbal 
dopamine (DA) and noradrenaline 
(NA) significantly differed between 
5-HTT-/- and 5-HTT+/+ rats (n.s. 
= non-significant change). (g) 
Maximum COC-induced increase 
of extracellular accumbal serotonin 
in (5-HTT-/-) rats that lack serotonin 
transporters (Student’s t-test: 
*P<0.05). Open symbols (O/☐) 
represent a significant increase 
relative to baseline (one sample 
t-test vs. 100%). Data are 
expressed as mean ± SEM (n=5 
rats/group).
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Figure 2. Hippocampus 
monoamine levels before and 
after cocaine (COC: 10 mg/kg). 
(a) Increased baseline levels of 
extracellular serotonin (5-HT) in 
the ventral hippocampus of 5-HTT-
/- rats (Student’s t-test: *P<0.05). 
(b) Reduction in the COC-
induced increase of extracellular 
hippocampal serotonin (5-HT) in 
5-HTT-/- rats (ANOVA: time effect: 
P<0.05; genotype x time effect: 
P<0.05, Student’s t-test: *P<0.05). 
(c-f) No significant (n.s.) genotype 
differences in either baseline 
levels or COC-induced increases 
of hippocampal dopamine (DA) 
and noradrenaline (NA). (g) 
Maximum COC-induced increase 
of extracellular hippocampal 
serotonin in (5-HTT-/-) rats that lack 
serotonin transporters (Student’s 
t-test: *P<0.05). Open symbols 
(O/☐) represent a significant 
increase relative to baseline (one 
sample t-test vs. 100%). Data are 
expressed as mean ± SEM (n=5 
rats/group).
Discussion
Remarkably, COC significantly increased the extracellular levels of serotonin in 5-HTT-
/- rats (figure 1g and 2g). The finding that COC increases the extracellular levels 
of serotonin in rats lacking serotonin transporters may very well be explained by our 
previously reported hypothesis that COC, like MDMA, releases neurotransmitters from 
storage vesicles (Verheij and Cools, 2011; Verheij et al., 2008; Verheij et al., 2013). The 
previously reported finding that the electrically-evoked release of central serotonin is 
smaller in 5-HTT-/- than 5-HTT+/+ rats (Homberg et al., 2007) indicates that the contribution 
of (vesicular) release to the COC-induced extracellular serotonin increase is also smaller 
in 5-HTT-/- than 5-HTT+/+ rats. Our previous and present data, therefore, underline the 
notion of Oakly et al. (2014) that a reduction in the evoked (vesicular) release of serotonin 
may have contributed to the enhanced acquisition of psychostimulant intake observed in 
individuals with a genetic deletion of plasmalemmal serotonin transporters (Oakly et al., 
2014). Given that reduced binding of serotonin to its receptors in the nucleus accumbens 
prevents both the rewarding effects of cocaine and the behavioral sensitization to this 
drug (Filip and Cunningham, 2002; Przegalinski et al., 2002; Zayara et al., 2011), we 
hypothesize that a decrease of COC-induced serotonin release in brain regions other 
than the nucleus accumbens (e.g., the hippocampus) mediates the enhanced cocaine 
self-administration of 5-HTT-/- rats. Additional studies are under way.
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ChapterD-Cycloserine enhanced 
extinction of cocaine-
induced conditioned place 
preference is attenuated 
in serotonin transporter 
knockout rats 
“WHAT CAN THE HARVEST HOPE FOR, IF NOT THE CARE OF THE REAPER MAN”
Death of the Discworld (Reaper Man - Sir Terry Pratchett)
Peter Karel, Francesca Calabrese, Marco A. Riva, 
Paola Brivio, Bas van der Veen, Liesbeth Reneman, 
Michel M.M. Verheij, Judith R. Homberg
Addiction Biology 2018 Jan;23(1):120-129.
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Abstract
D-cycloserine (DCS), a partial NMDA receptor agonist, has been proposed as a cognitive 
enhancer to facilitate the extinction of drug-related memories. However, it is unknown 
whether there are individual differences in the efficacy of DCS. Here we set out to 
investigate the influence of serotonin transporter (5-HTT) genotype on DCS treatment 
outcome and the underlying neural mechanism. To that end, we first determined the 
mRNA levels of several NMDA receptor subunits and observed a reduction in NR1/NR2C 
receptors in the ventromedial prefrontal cortex (vmPFC) and nucleus accumbens (NAc) 
of 5-HTT-/- compared to 5-HTT+/+ rats. Based on this finding we hypothesized a lower 
sensitivity to DCS in the 5-HTT-/- rats. To test this, rats were trained in a cocaine-induced 
conditioned place preference (CPP) paradigm. A significant extinction of CPP was 
observed in 5-HTT+/+ rats receiving 1 mg/kg i.v. DCS while in the 5-HTT-/- rats a similar 
effect was found only after 5 mg/kg. Following CPP we tested if DCS was able to reduce 
FosB/∆FosB protein expression, a molecular switch for cocaine seeking behavior. We 
observed an overall lower number of FosB/∆FosB positive cells in 5-HTT-/- vmPFC and 
amygdala and an overall effect of DCS treatment on the number of positive cells in the 
NAc. In conclusion, in this study, we show that the dosing of DCS to facilitate the extinction 
of cocaine seeking behavior is, at least partially, determined by 5-HTT genotype.
Introduction
Carriers of the short (s)-allele of the serotonin transporter linked polymorphic region 
(5-HTTLPR) exhibit a lower level of serotonin transporter (5-HTT) mRNA transcription 
and are hypothesized to have higher levels of extracellular brain serotonin (Heils et al., 
1996). These individuals may have an increased risk to become addicted to different 
types of drugs (Cao et al., 2013; Feinn et al., 2005; Gokturk et al., 2008). An animal 
model mimicking the 5-HTTLPR s-allele is the serotonin transporter knockout (5-HTT-
/-) rat (Homberg et al., 2007; Smits et al., 2006). 5-HTT-/- rats self-administer more 
cocaine in long and short access paradigms (Homberg et al., 2008; Verheij et al., 2012), 
measuring regular and compulsive cocaine self-administration behavior, respectively 
(Ahmed and Koob, 1998). 5-HTT-/- rats furthermore exhibit increased cocaine-induced 
place preference (CPP) compared to wild-type (5-HTT+/+) controls (Homberg et al., 
2008). Importantly, these rats also display a difficulty in extinguishing cocaine- and fear-
associated memories (Homberg et al., 2008; Nonkes et al., 2012a; Schipper et al., 2011). 
A potential mechanism underlying this extinction deficit involves decreased top-down 
control of the ventromedial prefrontal cortex (vmPFC) over limbic structures such as the 
amygdala (Amy) and the nucleus accumbens (NAc) (Peters et al., 2009). Projections from 
the vmPFC to these areas are glutamatergic and are essential for the consolidation of 
extinction learning (Burgos-Robles et al., 2007; LaLumiere et al., 2010). Furthermore, the 
glutamatergic system is implicated in reward-related learning (Popik et al., 2006). It has 
been previously observed that 5-HTT-/- rodents exhibit a lower vmPFC and higher Amy 
activation during fear extinction (recall) (Pang et al., 2011). Additionally, morphological 
changes of glutamatergic pyramidal neurons in the PFC and amygdala associated with 
reduced fear extinction recall (Wellman et al., 2007) have suggested a comparable 
neural hallmark in 5-HTT-/- rodents. These data suggest that the neural circuit implicated 
in the extinction of fear- and reward-related memories exhibits changes in glutamatergic 
neurotransmission in 5-HTT-/- rats.
Stimulating glutamatergic neurotransmission, using the partial N-methyl-D-aspartate 
(NMDA) receptor agonist D-cycloserine (DCS), may provide a good basis for remediation 
of reduced extinction of cocaine related memories in 5-HTT-/- rodents. In 2006, Botreau 
et al., inspired addiction research by showing that DCS, which was previously found 
to facilitate fear extinction in humans and rodents (Ledgerwood et al., 2003; Walker et 
al., 2002), reduced drug-seeking in a cocaine-induced CPP test when administered 
systematically (15 mg/kg i.p.) or locally into the amygdala (10 µg/side), (Botreau et 
al., 2006). This DCS effect was replicated in rats self-administrating cocaine using a 
higher dose of DCS (30 mg/kg i.p.) (Thanos et al., 2011) and later translated to humans 
responding to smoking- or alcohol-related cues (MacKillop et al., 2015; Santa Ana et al., 
2009). Notably, not all subsequent human studies were able to replicate these findings Ch
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for cocaine (Kennedy et al., 2012; Santa Ana et al., 2015). A possible explanation is 
the presence of individual variability in responsivity to DCS, which may mask the effect 
of DCS in a subgroup of addicts who may benefit from treatment. To illustrate this, De 
Kleine et al. (2014) identified personality traits and demographic factors that predicted 
DCS treatment efficiency in a group of post-traumatic stress disorder patients (De Kleine 
et al., 2014).
In the present study, we set up experiments to investigate if 5-HTT genotype influences 
the efficacy of DCS to facilitate the extinction of cocaine seeking behavior. Firstly, 
we show altered mRNA expression of specific NMDA receptor (NMDAR) subunits in 
the vmPFC and amygdala of naïve 5-HTT-/- rats. Accordingly, it is our first hypothesis 
that DCS less effectively facilitates the extinction of cocaine-induced CPP in 5-HTT-/- 
compared to 5-HTT+/+ rats. To confirm this, we demonstrate that 5-HTT-/- rats required a 
higher DCS dose to facilitate extinction of cocaine seeking behavior in a cocaine-induced 
CPP test. Finally, to delineate the neuronal correlates of the DCS effects on extinction we 
assessed neuronal activity using FosB/∆FosB immunohistochemistry. The remarkably 
stable isoform of the FOSB gene, ∆FosB, accumulates in several brain areas after 
repeated administration of cocaine. Because ∆FosB induction induces cocaine seeking 
in the CPP and self-administration paradigms (Kelz et al., 1999; Nestler et al., 2001) it 
is our second hypothesis that DCS facilitated reduction of cocaine seeking behavior as 
function of 5-HTT genotype is accompanied by a change in ∆FosB expression in the 
vmPFC, NAc and Amy. 
Materials & Methods
Animals
All experiments were approved by the Committee for Animal Experiments (DEC 2011-
147) of the Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 
and all efforts were made to minimalize animal suffering and to reduce the number of 
rats used.
5-HTT knockout rats (5-HTT-/-, Slc6a41Hubr) were generated on a Wistar background 
by ENU-induced mutagenesis (Smits et al., 2004) and have been described previously 
(Homberg et al., 2007). Heterozygous 5-HTT knockout (5-HTT+/−) rats, that had been 
outcrossed for at least fifteen generations with wild-type Wistar rats obtained from 
Charles River Laboratories (Köln, Germany), were crossed to derive experimental male 
5-HTT−/− and 5-HTT+/+ rats. Rats started testing at the age of PND 80-90. After weaning at 
the age of 21 days, ear punches were taken for genotyping. Genotyping was performed 
by Kbioscience (Hoddesdon, United Kingdom) and the procedure of genotyping has 
been described elsewhere (Homberg et al., 2007). Rats were housed in Plexiglas cages 
in pairs in a temperature (21 ± 1 °C) and humidity-controlled room (60 ± 15% relative 
humidity), and had ad libitum access to water and food, except during testing. After 
surgery, rats were housed individually. A 12-hour light–dark cycle was maintained; with 
lights on at 08:00 a.m. Researchers analyzing behavioral data or animal tissues were 
blinded to the experimental condition and/or genotype. 
NMDAR mRNA extraction and qRT-PCR
For NMDAR mRNA analysis naïve adult rats (PND 80-90) were decapitated and the 
brains were frozen in aluminum foil on dry ice. The brains were stored at -80°C and cut 
into 200 μm slices using a Microm HM500O cryostat (GMI, inc., USA). The vmPFC, 
nucleus accumbens (NAc) and amygdala (Amy) were then excised according the 
Paxinos and Watson rat brain atlas using Harris Uni-CoreTM 2.0 (vmPFC) or Uni-CoreTM 
1.2 (NAc and Amy) punches (Jed Pella, inc., USA) and stored at -80°C until further 
processing (Paxinos and Watson, 2006). Total RNA was isolated by a single step of 
guanidinium isothiocyanate/phenol extraction using PureZol RNA isolation reagent (Bio-
Rad Laboratories, Italy) according with the manufacturer’s instructions and quantified by 
spectrophotometric analysis. Following total RNA extraction, the samples were processed 
for real-time polymerase chain reaction (RT-PCR) to assess NR1, NR2A, NR2B, NR2C 
and NR2D mRNA levels. An aliquot of each sample was treated with DNase (Tebu-bio, 
Italy) to avoid DNA contamination. RNA was analyzed by a TaqMan qRTPCR instrument 
(CFX384 real time system, Bio-Rad Laboratories, Italy) using the iScriptTM one-step RT-
PCR kit for probes (Bio-Rad Laboratories, Italy). Samples were run in 384 well formats 
in triplicate as multiplexed reactions with a normalizing internal control (β-actin). The 
primer probes were purchased from Eurofins MWG-Operon. The primer sequences can 
be found in Table S1 and have been reported previously (Calabrese et al., 2012).
Thermal cycling was initiated with an incubation at 50°C for 10 min (RNA retrotranscription) 
and then at 95°C for 5 min (TaqMan polymerase activation). After this initial step, 39 cycles 
of PCR were performed. Each PCR cycle consisted of heating the samples at 95°C for 10 
s to enable the melting process and then for 30 s at 60°C for the annealing and extension 
reactions. A comparative cycle threshold (Ct) method was used to calculate the relative 
target gene expression.
Surgery 
We chose to apply DCS through the intravenous route for alignment of the present CPP 
study with future intravenous cocaine self-administration and pharmacological magnetic 
resonance experiments. Intravenous catheters were implanted in the right jugular vein 
of 56 rats under isoflurane anesthesia (initially 5%, during surgery 2-3%, for more details 
see (De Vries et al., 1998). After surgery, the rats were allowed to recover for a minimum 
of 1 week before testing started. Catheter patency was maintained by daily sterile saline-
heparin (0.1 ml; 13.5 mg/ml, 140 units/mg) infusions.Ch
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Apparatus 
CPP experiments took place in two, three-compartment place conditioning boxes 
comprising of two identically sized conditioning chambers (27.0 cm × 27.0 cm × 26.0 
cm, l × w × h), and a neutral middle compartment (10.0 × 27.0 × 26.0 cm l x w x h). 
For contextual discrimination, one of the conditioning chambers had black and white 
checkered walls and a stainless steel grid floor. The grid floor consisted out of eighteen 
stainless steel bars (ø = 6 mm) which were separated (center-center) by 8 mm. The 
other conditioning chamber had black and white striped walls and a black fine wire 
mesh floor. A reservoir with black bedding was located underneath each grid for waste 
collection. The middle compartment contained white walls and a grid floor of ten steel 
bars (ø = 4 mm) which were separated (center-center) by 6 mm. The steel bars were 
situated along the length of the compartment, at a 90 degree angle of the rods of the 
checkered conditioning chamber. Removable inserts between the chambers allowed the 
rats to either explore the entire apparatus or be confined to one conditioning chamber. A 
camera (Sony, Japan) connected to a PC running Ethovision 3.1 software (Noldus, the 
Netherlands) was mounted near the ceiling enabling live position tracking of the rats. 
Conditioned place preference 
CPP experiments comprised of 3 phases which spanned a total of 11 days, pretest (1d), 
conditioning (8d), and posttests (2d). During the pretest, the rats (5-HTT+/+ n=31; 5-HTT-
/- n=25) were placed in the middle compartment and were then allowed to explore all 
three chambers freely for fifteen minutes in order to determine the initial preference of 
the rats. Cocaine paired chambers (CS+) were assigned in a counter balanced fashion, 
meaning that half the rats were conditioned in their initially preferred compartment 
and half in their initially non-preferred compartment (effort was made to attain a 50-
50 distribution of checked and striped CS+ compartments). During the conditioning 
phase rats were injected with either cocaine (CS+, 10 mg/kg, 1 ml/kg) or saline (CS-, 
1 ml/kg) on alternating days (Homberg et al., 2008). The rats were then confined the 
corresponding conditioning chamber for 40 minutes. Twenty four hours after the last 
conditioning session a 15 minute post-test was performed, in which the rats were placed 
in the middle compartment and allowed to freely explore all compartments in a cocaine 
free state. Directly after this first post-test 0, 1 or 5 mg/kg of DCS (Sigma-Aldrich, USA) 
was administered intravenously. Twenty four hours later the effects of DCS on CPP 
were tested by performing an additional 15 minute posttest. End variable (∆CS+) was 
calculated by subtracting time spent in CS+ compartment during pretest from time spent 
in CS+ compartment during each of the posttests (Homberg et al., 2008).
Tissue preparation
For ∆FosB staining, the rats that performed CPP were anesthetized 24 hours after the 
final posttest using 120 mg/kg pentobarbital after which they were transcardially perfused 
using 0.1M phosphate buffered saline (PBS, pH = 7.2) and 4% paraformaldehyde (PFA, 
pH= 7.3) to fix the brains. The brains were then removed from the skulls and stored 
overnight in 4% PFA at 4 °C for post fixation. The next day the PFA was replaced with 
0.1M PBS containing 0.05% sodium azide. Prior to sectioning, brains were transferred to 
30% sucrose solution at room temperature for two days and a freezing microtome was 
used to slice sections of 40 µm. The slices were stored in PBS containing azide until 
immunostaining.
FosB/∆FosB Immunohistochemistry 
Because no reliable commercially available antibody for ∆FosB exists, we used 
an antibody that labels both FosB and ∆FosB and sacrificed animals 24 hours after 
performing the last posttest. Therefore, any differences found in FosB/∆FosB expression 
are likely caused by ∆FosB (El Rawas et al., 2012; Hope et al., 1994; Perrotti et al., 2008).
Slices were taken from storage and washed three times for 10 minutes in 0.1M PBS (pH 
= 7.2). Endogenous peroxidase activity was blocked by incubating the slices in 0.1M PBS 
containing 1% hydrogen peroxide. After 3 washing steps the tissue was pre-incubated for 
1 hour with 0.1M PBS containing 0.1% bovine serum albumin (Sigma-Aldrich) and 0.5% 
Triton X-100 (Sigma-Aldrich, PBS-BT). After this pre-incubation period a rabbit anti-FosB 
antibody (sc-48, Santa Cruz, 1:2000) was added and left to incubate overnight (El Rawas 
et al., 2012). The slices were then washed three times using 0.1M PBS and incubated with 
a donkey anti-rabbit biotin conjugated antibody (Jackson ImmunoResearch Laboratories, 
1:1500 in PBS-BT) for 90 minutes. After three more washing steps the slices were 
incubated with ABC vector elite (1:800 in PBS-BT). Following 3 more washing steps 
immunolabeling was visualized by 3,3-diaminobenzedine tetrahydrochloride (DAB). To 
this end, sections were incubated for 10 min in a solution containing 0.02% DAB and 
0.03% nickel-ammonium sulphate in 0.05M Tris buffer (pH = 7.6) after which 0.006% 
hydrogen peroxide was added for 10 min. The reaction was then stopped by washing three 
times in PBS. Subsequently, the slices were mounted on gelatin chrome alum-coated 
glass slides, dried overnight at 37°C, dehydrated in ascending alcohol concentrations, 
cleared in Xylol (Merck), embedded in Entellan (Merck), and coverslipped.
Statistical analysis 
All statistical analyses were performed using IBM SPSS version 20.0 (IBM software, 
USA). All data were checked for outliers and normality (using the Shapiro-Wilk statistic). 
NMDAR subunit mRNA expression was compared using genotype (2 levels) x subunit (5 
levels) univariate analysis of variance (ANOVAs). Post-hoc independent samples t-tests 
were performed where applicable. To assess whether cocaine-induced CPP induction 
was successful the data from posttest 1 was pooled per genotype and one sample 
t-tests were performed. The overall effects of genotype and DCS treatment on CPP and Ch
ap
te
r 4
  |
  D
CS
 e
nh
an
ce
d 
ex
tin
ct
io
n 
of
 C
PP
  
54 55
locomotor activity were analyzed using a genotype (2 levels) x dose (3 levels) x time 
(2 levels) repeated measures ANOVA. Post-hoc paired samples t-tests were performed 
when appropriate. ΔFosB immunoreactivity was analyzed using genotype (2 levels) x 
dose (3 levels) univariate ANOVAs. Level of significance was set at p<0.05 and non-
significant effects are indicated by p = NS. 
Results 
NMDAR subunit expression
Relevant NMDAR subunits were analyzed in the vmPFC, NAc and Amy. As is shown in 
Figure 1, there was a significant genotype*subunit effect in the vmPFC (F(4,109) = 30.695, 
p<0.001) and NAc (F(4,110) = 3.726, p<0.01). Post-hoc analysis revealed that, compared 
to 5-HTT+/+ rats, 5-HTT-/- rats had a higher expression of NR2A (t(22)=8.62, p<0.001) and 
lower expression of NR1 (t(21)=-3.02, p<0.01) in the vmPFC and a lower expression of 
NR2C (t(22)=-5.13, p<0.001) in the NAc. All other genes did not differ significantly.
Figure 1. NMDAR subunit mRNA 
expression. Relative expression 
of NR1 and NR2 subunit mRNAs 
in vmPFC (A), Amy (B) and NAc (C) 
including diagrams representing 
where tissue was collected (adapted 
from Paxinos & Watson brain atlas). 
5-HTT+/+ rats are represented by white 
bars and 5-HTT-/- rats by grey bars, all 
data represent mean (±SEM). Overall 
genotype*subunit interaction was 
found in the vmPFC (#F(4,109) = 30.695, 
p<0.001) and NAc ($F(4,110) =3.726, 
p<0.01). Post hoc independent 
samples t-test analysis revealed that 
5-HTT-/- rats show a lower expression 
of NR1 (**t(21) = -3.017, p<0.01) and 
higher expression of NR2A in the 
vmPFC (***t(22) = 8.620, p<0.001) as 
well as a lower expression of NR2C in 
the NAc (***t(22) = -5.129, p<0.001). 
Conditioned place preference
Data acquired during posttest 1 were pooled per genotype as displayed in Figure 2. Both 
5-HTT+/+ and 5-HTT-/- rats were able to acquire CPP (one sample t-test, 5-HTT+/+: t(30) 
= 3.027, p<0.05; 5-HTT-/-: t(22) = 3.607, p<0.05). No difference between genotypes was 
observed (independent samples t-test, t(1,52) = 0.459, p = NS). 
Figure 2. Posttest 1 place preference induction in 5-HTT+/+ and 
5-HTT-/- rats. 5-HTT+/+ rats are represented by white bars and 5-HTT-
/- rats by grey bars, ∆CS+ was calculated by subtracting time spent in 
CS+ compartment during pretest from time spent in CS+ compartment 
during the first posttest. All data are represented as mean (±SEM). 
A) ∆CS+ representing cocaine-induced CPP in 5-HTT+/+ versus 
5-HTT-/- rats during posttest 1. Both genotypes were able to acquire 
CPP (one sample t-test, 5-HTT+/+: t(30) = 3.027, *p<0.05; 5-HTT
-/-: t(22) 
= 3.607, *p<0.05). No difference between genotypes was observed 
(independent samples t-test, t(1,52) = 0.459, p = NS).
For visualizing the effects of DCS on the extinction of CPP, data acquired during posttest 
1 and 2 were split per genotype as seen in Figure 3A and B. Repeated measures ANOVA 
revealed a significant dose*time interaction (F(2, 48) = 3.198, p<0.05). Post hoc paired 
samples t-tests between CPP measured on posttest I and II revealed that vehicle treated 
rats had no significant extinction of their CPP (5-HTT+/+: t(9) = -0.490, p = NS and 5-HTT
-/-: 
t(7) = -0.866, p = NS. However, CPP was significantly reduced in 5-HTT
+/+ (t(10) = 3.575, 
p<0.01) but not 5-HTT-/- (t(6) = 0.414, p = NS) rats that received 1 mg/kg DCS. In contrast, 
CPP was significantly reduced in 5-HTT-/- (t(7) = 2.465, p<0.05) but not in 5-HTT
+/+ (t(9) = 
1.225, p = NS) rats that received 5 mg/kg DCS. Place preference behavior can be divided 
into several components (Huston et al., 2013). In supplementary figure S1A and S1B we 
show that the number of CS+ compartment entries and the time per CS+ entry did not 
differ between genotypes, nor were they influenced by DCS treatment (entries: repeated 
measures ANOVA F(2,48) = 1.373, p = NS, time per entry: repeated measures ANOVA: 
F(2,48) = 1.453, p = NS). General locomotor activity (expressed as distance moved) during 
both posttests is shown in Figure S1C. No significant difference in locomotor activity was 
observed using a repeated measures ANOVA (F(2, 48) = 0.407, p = NS).
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Figure 3. Effects of single i.v. DCS 
injection on conditioned place preference 
behavior of 5-HTT+/+ and 5-HTT-/- rats. For 
visual clarity 5-HTT+/+ rats are represented 
in figure A and 5-HTT-/- in figure B, all data 
represented mean of ∆CS+ (±SEM) and both 
genotypes were analyzed together. ∆CS+ 
was calculated by subtracting time spent in 
CS+ compartment during pretest from time 
spent in CS+ compartment during each of 
the posttests. Data acquired during posttest 
I is represented by white bars and posttest II 
by grey bars. Repeated measures ANOVA 
revealed a significant DCS dose*posttest 
interaction (#F(2,48) = 3.198,
 p<0.05). Post hoc 
paired samples t-tests revealed a significant 
lower CPP during posttest II in 5-HTT+/+ rats 
treated with 1 mg/kg DCS (n=11, **t(10) = 
3.575, p<0.01) and 5-HTT-/- rats treated with 
5 mg/kg DCS (n=8, *t(7)=2.465, p<0.05). No 
reduction of CPP was observed in control 
rats (0 mg/kg, 5-HTT+/+ n=10, 5-HTT-/- n=8), 
5-HTT-/- treated with 1 mg/kg (n=7) DCS 
and 5-HTT+/+ rats treated with 5 mg/kg DCS 
(n=10).
Immunohistochemistry 
24 hours after the last posttest animals were transcardially perfused and slices were 
stained for FosB/∆FosB. Figures 4A-C show the density of positive cells that was 
assessed in vmPFC, NAc and Amy. 5-HTT-/- rats showed lower overall expression of 
∆FosB in the vmPFC (F(1, 46) = 6.433, p<0.05). Additionally, the density of ΔFosB positive 
cells in the Amy was significantly lower in 5-HTT-/- (F(1,46) = 4.665, p < 0.05) rats while 
there was a trend towards significance caused by the DCS treatment (F(2,46) = 3.018, p = 
0.059). The most robust treatment effect was observed in the NAc where DCS treated 
animals showed an overall lower density of ∆FosB positive cells when compared to the 
vehicle control (F(2,47) = 7.469, p<0.01). 
Figure 4. FosB/∆FosB immunoreactivity in 5-HTT-/- 
rats after DCS assisted CPP. Relative expression of 
immunopositive cells in the vmPFC (A), NAc (B) and 
Amy (C). 5-HTT+/+ rats are represented as white bars 
and 5-HTT-/- as grey bars. All data are represented 
as mean of immunopositive cellular density (±SEM). 
The statistical outcome of the ANOVA is designated 
with (G) for overall genotype effect and (T) for overall 
DCS treatment effect. 5-HTT-/- rats displayed an overall 
lower number of FosB positive cells in the vmPFC 
(G*F(1,50)= 4.688, p<0.05) and Amy (
G*F(1,46) = 4.665, 
p<0.05). Additionally, DCS treatment seemed to lower 
the number of FosB positive cells in the NAc (T**F(2,49) = 
5.625, p<0.01).
Discussion 
In the experiments above we show that naïve 5-HTT-/- rats display changes in NMDAR 
subunit mRNA expression. More specifically, when compared to 5-HTT+/+ rats NR1 
subunit mRNA is reduced and NR2A subunit mRNA expression is increased in the 
vmPFC and NR2C subunit expression is reduced in the NAc of 5-HTT-/- rats. In line with 
this observation and our first hypothesis, we found that 5-HTT-/-, compared to 5-HTT+/+, 
rats required a higher dose of DCS to potentiate the extinction of cocaine-induced CPP. 
This suggests that 5-HTT-/- rats are less responsive to DCS. Contrary to our second 
hypothesis, these behavioral differences were not mirrored by reduced ∆FosB expression 
in the same groups. Nonetheless, we did observe significant genotype effects in the 
vmPFC and Amy and an effect of DCS treatment in the NAc. 
NMDARs are functional heterotetramers most often formed by combining two NR1 
subunits and two NR2 subunits. The NR1 subunits present in the protein contain the 
glycine binding site, and thus the binding site for DCS (Hood et al., 1989). Interestingly, it 
is the NR2 subunit that determines the efficacy of DCS on the receptor complex. As such, 
it has been shown that DCS exerts its function mostly through receptors consisting of Ch
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NR1 and NR2C subunits (NR1/NR2C receptors) and less through NR1/NR2A and NR1/
NR2B receptors (Dravid et al., 2010; Sheinin et al., 2001). We showed that the 5-HTT-/- 
rats have lower NR1 and higher NR2A subunit mRNA expression in the vmPFC. These 
results imply that there is, relative to NR1/NR2A and NR1/NR2B receptors, a lower 
number of NR1/NR2C receptors available for DCS to exhibit its beneficial effects during 
extinction consolidation. A similar shift in receptor ratio is seen in the NAc, although 
there it is caused by a direct downregulation of NR2C subunit mRNA. Functionally this 
is reflected by the higher DCS dose that was required in our 5-HTT-/- rats to facilitate 
extinction retention. 
Here we reproduced the finding reported by others (Botreau et al., 2006) that DCS 
increases the extinction of cocaine-induced CPP in wildtype rats and show that this is 
also possible in 5-HTT-/- rats at a higher dose. As mentioned in the introduction, some 
human studies reported beneficial effects of DCS on the extinction of cue-induced drug 
craving (MacKillop et al., 2015; Santa Ana et al., 2009). However, multiple human studies 
have found no effect of DCS on extinction of cocaine associated cues (Kennedy et al., 
2012; Santa Ana et al., 2015) or even enhanced reactivity after treatment (Price et al., 
2013; Prisciandaro et al., 2013). Although these contrasting outcomes may be related to 
methodological choices, it is also possible that these differences are dependent on the 
nature of the study population. In this light, we show here that the 5-HTT genotype may 
influence the efficacy of DCS to potentiate the extinction of cocaine-related memories. 
As the 5-HTT-/- rat model has higher levels of trait anxiety before and after cocaine 
administration (Homberg et al., 2008; Verheij et al., 2017), our results are in line with 
the findings by Ho et al. showing that the effectiveness of DCS is lowered in a rat model 
specifically bred for high anxiety compared to low anxiety counterparts (Ho et al., 2005). 
It is also noteworthy that the 5-HTT+/+ rats did not benefit from increased (5 mg/kg) DCS 
treatment suggesting an inverted U-shape functionality of DCS on behavior. The human 
studies mentioned above all used the same dose of DCS (50 mg), and all highlight the 
importance of dosing when discussing their results. In this light, our results confirm that 
there are individual differences in the effectiveness of as both genotypes only responded 
to a single (different) dose. 
∆FosB is a transcription factor that has been theorized to be a molecular switch for 
addiction behavior, where high levels of the protein in the nucleus accumbens triggers 
cocaine seeking (Nestler 2001). Here we hypothesized that ∆FosB immunoreactivity 
would go down as a result of DCS treatment. DCS is thought to reduce CPP through 
actions in the nucleus accumbens (Torregrossa et al 2010). In line with this, we observed 
a significant DCS dose effect (independent of genotype) in this brain area. Additionally, 
the NAc is also the brain area to which most drug seeking effects of ∆FosB are attributed 
(Nestler, 2008). We also observed overall lower expression of ∆FosB in 5-HTT-/- rats 
(irrespective of DCS dose) in the vmPFC and Amy. Even though it has been shown that, 
like in the NAc, repeated drug administration induces ∆FosB in these areas (Perrotti et al., 
2008) the role of ∆FosB in cocaine seeking behavior in these areas has not been extensively 
researched. Interestingly, the finding that ∆FosB expression is reduced in the vmPFC 
of 5-HTT-/- versus 5-HTT+/+ rats is in line with previous observations of reduced vmPFC 
activity and immediate early gene expression in 5-HTT-/- versus 5-HTT+/+ rats (Molteni et al., 
2009; Pang et al., 2011), as well as reduced medial prefrontal activity in human 5-HTTLPR 
s-allele carriers exposed to emotion provoking stimuli (Munafo et al., 2008; Pezawas et 
al., 2005). The lower FosB/∆FosB immunoreactivity in the Amy of 5-HTT-/- versus 5-HTT+/+ 
rats seems to contradict previous studies reporting increased baseline Amy (re)activity in 
5-HTT-/- rodents and humans carrying the 5-HTTLPR s-allele (Hariri et al., 2002; Pang et al., 
2011). Yet, since we do not know which neurons expressed FosB/∆FosB additional studies 
are needed to properly interpret these findings in terms of area activity levels. Even though 
these past observations in vmPFC and Amy were made under drug-free conditions and 
therefore may not reflect the same neurobiological state, FosB/∆FosB immunoreactivity 
is lowered in the vmPFC and NaC of animals that are susceptive to develop anxiety and 
depression like behaviors after social defeat stress (Vialou et al., 2014). Since 5-HTT-/- 
rodents show depression- and anxiety-like behavior (Holmes et al., 2003b; Olivier et al., 
2008), which is also more exaggerated after social defeat stress (Jansen et al., 2010), it 
is possible that the lower FosB/∆FosB expression observed here reflects an anxious state 
and is not (or not exclusively) related to DCS treatment.
There are some shortcomings in the present study. Differences in mRNA expression 
do not always translate to differences in protein expression. However, the effect size 
of especially the NR2A subunit in vmPFC is quite considerable and as such is likely to 
translate into differences at the protein level. To further determine the respective roles of 
different NMDARs in the working mechanism of DCS it could be crucial for future studies 
to examine the NMDAR composition in the projection terminals of the vmPFC (e.g. Amy 
and NAc) to confirm these mRNA results. Furthermore, we were unable to reproduce 
our finding that cocaine induced CPP is increased in the 5-HTT-/- rats (Homberg et al., 
2008). This discrepancy may be attributed to major differences in methodology. In the 
present study animals required surgery and single housing which may have altered their 
sensitivity to cocaine (Nader et al., 2012). Additionally, we only used a single injection 
of DCS to extinguish CPP seeking behavior and are therefore unaware what repeated 
exposure may reveal. 
In conclusion, above we show that a genetic variation in serotonin transporter expression 
can be a predictor for the efficiency of D-cycloserine. It is possible that this reduction 
in sensitivity to DCS treatment is caused by a lower expression of NR1/NR2C NMDA 
receptors. Future studies should focus on confirming this difference in the expression on 
the protein level and the underlying mechanisms causing this shift.Ch
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Supplementary materials 
Table S1. NMDAR subunit qPCR primers and probes.
Gene Forward primer Reverse primer Probe
NR1 TCATCTCTAGCCAGGTCTACG CAGAGTAGATGGACATTCGGG TGGGAGTGAAGTGGTCGTTGGG
NR2A GCACCAGTACATGACCAGATTC ACCAGTTTACAGCCTTCATCC CGTCCAACTTCCCGGTTTTCAAGC
NR2B TTCATGGGTGTCTGTTCTGG GGATGTTGGAGTGGGTGTTG TCATCACGGATTGGCGCTCCT
NR2C TTATGGTATCAAGGAGCAACGG TCGAACATGAAGACAGTGATGG AGCTTTTCTGGAACCCTACAGCCC
NR2D CCCTTTGTAGAGACAGGCATC GATGAAAACTGTGACGGCG ACGGTGAGGCACATGACGAACA
β-actin CACTTTCTACAATGAGCTGCG CTGGATGGCTACGTACATGG TCTGGGTCATCTTTTCACGGTTGGC
Figure S1. CPP CS+ entries and locomotion 
behavior. 5-HTT+/+ rats are represented by white bars 
and 5-HTT-/- rats by grey bars, all data represent mean 
(±SEM). A) CS+ entries of 5-HTT+/+ and 5-HTT-/- rats 
during posttest 1 and 2. CS+ entries did not change by 
treatment or genotype (repeated measures ANOVA F(2,48) 
= 1.373, p = NS). B) Time spent in CS+ compartment 
per visit was neither influenced by DCS treatment nor 
by DCS treatment (repeated measures ANOVA F(2,48) = 
1.453, p = NS). C) Locomotion of 5-HTT+/+ and 5-HTT-/- 
did not change between the posttests and did not differ 
between genotypes (repeated measures ANOVA, F(2, 48) 
= 0.407, p = NS)
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ChapterAppetitive to aversive 
counter-conditioning as 
intervention to reduce 
reinstatement of reward 
seeking behavior: the 
role of the serotonin 
transporter
“A journey will have pain and failure. 
It is not only the steps forward that we must accept. 
It is the stumbles. The trials. The knowledge that we will fail. 
That we will hurt those around us. But if we stop, 
if we accept the person we are when we fail, the journey ends. 
That failure becomes our destination.” 
Dalinar Kohlin (Oathbringer - Brandon Sanderson) 
Peter Karel, Amanda Almacellas-Barbanoj, 
Jeffrey Prijn, Anne-Marije Kaag, Liesbeth Reneman, 
Michel M.M. Verheij, Judith R. Homberg
Addiction Biology 2018 Jan 2 [Epub ahead of print]
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Abstract 
Counter-conditioning can be a valid strategy to reduce reinstatement of reward seeking 
behavior. However, this has not been tested in laboratory animals with extended cocaine 
taking backgrounds, nor is it well understood which individual differences may contribute 
to its effects. Here, we set out to investigate the influence of serotonin transporter (5-HTT) 
genotype on the effectiveness of counter-conditioning on reinstatement after extended 
access to cocaine self-administration. To this end, 5-HTT+/+ and 5-HTT-/- rats underwent a 
touch screen-based approach to test if reward-induced reinstatement of responding to a 
previously counter-conditioned cue is reduced, compared to a non-counter-conditioned 
cue, in a within-subject manner. We observed an overall extinction deficit of cocaine 
seeking behavior in 5-HTT-/- rats and a resistance to punishment during the counter-
conditioning session. Furthermore, we observed a significant decrease in reinstatement 
to cocaine and sucrose associated cues after counter-conditioning, but only in 5-HTT+/+ 
rats. In short, we conclude that the paradigm we used was able to produce effects 
of counter-conditioning of sucrose seeking behavior in line with what is described in 
literature, and we demonstrate that it can be effective even after long-term exposure to 
cocaine, in a genotype-dependent manner. 
Introduction
In humans dealing with drug addiction problems, relapse rates are high (Hubbard et 
al., 2003). In laboratory animals, reinstatement of drug self-administration, a model for 
human drug relapse, can occur spontaneously, after drug associated cue exposure or 
after re-exposure to the drug itself (Shaham et al., 2003). The fact that reinstatement 
occurs after prolonged periods of extinction underlines the importance of research into 
new treatment options for drug addiction.
Generally, during appetitive conditioning, a conditioned stimulus (CS+) is paired with 
a rewarding unconditioned stimulus (US) and subsequently becomes rewarding itself, 
driving reward-seeking behavior. The purpose of extinction is to reduce reward seeking 
behavior by exposing individuals to the CS+ without reward; thereby forming a new, 
dominant, memory trace (for review see: Quirk and Mueller, 2008). However, multiple 
studies have shown that this strategy is not sufficient to reduce drug seeking. In counter-
conditioning, the previously rewarding CS+ is coupled to an aversive US (e.g. foot 
shock) instead of a CS+ without US. While research using this method is sparse, it has 
been shown to enhance conventional extinction as well as to reduce reinstatement in 
laboratory animals with limited cocaine taking history (Tunstall et al., 2012) and healthy 
humans receiving natural rewards (Kaag et al., 2016; Kerkhof et al., 2011). These findings 
suggest that counter-conditioning may be a valid strategy to reduce reinstatement. 
However, it remains unclear if this strategy will prove sufficient in animals with extended 
cocaine taking histories. Therefore, it is our first hypothesis that counter-conditioning is 
an effective tool to reduce reinstatement of reward seeking in rats with a history of at least 
20 cocaine self-administration sessions of 6 hours per session. 
One genetic factor influencing the acquisition and extinction of conditioned behaviors 
involves the low activity short (s)-allelic variant of the serotonin transporter linked 
polymorphic region (5-HTTLPR). S-allele carriers show increased acquisition of fear 
(Garpenstrand et al., 2001) or increased activation of several brain regions such as the 
amygdala and anterior cingulate cortex, during fear conditioning (Klucken et al., 2015). 
Increased activation of these regions has been linked to increased attention to salient 
stimuli (Homberg and Lesch, 2011; Klucken et al., 2013). Furthermore, s-allele carriers 
may be at increased risk to develop substance use disorders (Cao et al., 2013; Feinn 
et al., 2005; Gokturk et al., 2008). Increased cue reactivity is an important driving factor 
for fear conditioning and in cocaine seeking and relapse (Volkow et al., 2006). Previous 
research has shown that s-allele carriers have both increased negative emotional cue 
reactivity and an attentional bias towards positive stimuli compared to l-allele controls 
(Beevers et al., 2009) and show increased reversal learning (Finger et al., 2007). In 
concordance with the ‘for-better-or-worse’ concept for gene x environment interactions 
(Belsky et al., 2009), this may - on the one hand - provide a potential cause of increased Ch
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addiction sensitivity, and - on the other hand - an opportunity for treatment using counter-
conditioning in this population.
To test this idea in a controlled manner, the serotonin transporter knockout (5-HTT-/-) 
rat, modeling the 5-HTTLPR s-allele (Caspi et al., 2010; Homberg et al., 2007; Smits et 
al., 2006), has been used. Genetic knockout of 5-HTT in these rats causes a complete 
absence of 5-HTT protein in the brain, as was shown previously using autoradiography 
(Homberg et al., 2007). Furthermore, behavior of 5-HTT-/- rats is strongly cue-dependent 
(Nonkes et al., 2012b; Schipper et al., 2011). Moreover, 5-HTT-/- rats have been found to 
self-administer more cocaine in short and long access paradigms (Homberg et al., 2008), 
measuring regular and compulsive cocaine self-administration behavior, respectively 
(Ahmed and Koob, 1998). These 5-HTT-/- rats also show decreased extinction of cocaine-
seeking behavior (Homberg et al., 2008; Verheij et al., 2017). On the other hand, 5-HTT-
/- rats exhibit higher cognitive flexibility, as illustrated by improved reversal learning of 
sucrose (appetitive to appetitive switch), and faster fear extinction when also presented 
with a cue predicting food delivery (aversive to appetitive switch) (Nonkes et al., 2012a; 
Nonkes et al., 2013). Based on these findings it is our second hypothesis that 5-HTT-
/- rats benefit more from appetitive to aversive counter-conditioning compared to their 
5-HTT+/+ counterparts. 
Here we present a touchscreen-based counterconditioning paradigm that was able to 
reduce the reinstatement of sucrose and cocaine-seeking behavior. We have compared 
the efficacy of counter-conditioning to that of typical extinction training in a within subject 
experimental design. Our touchscreen equipped behavioral cages (for review see: Talpos 
and Steckler, 2013), enabled us to train rats to associate several distinct visual cues with 
reward or punishment within the same sensory dimension (sight), preventing bias. Two 
groups of rats were trained to self-administer sucrose or cocaine in response to several 
distinct visual discriminative cues, using the touch-screen itself as manipulandum. 
Afterwards we counter-conditioned one of these visual cues while using typical extinction 
on the other cue, enabling us to measure the effectiveness of counter-conditioning in a 
within-subject design. After full extinction of reward-seeking behavior, we exposed the 
animals to either sucrose or cocaine reward and measured reinstatement of sucrose and 
cocaine-seeking behavior. 
Materials & Methods
Animals 
Surgery
Rats used for cocaine self-administration were equipped with intravenous catheters 
implanted in the right jugular vein using isoflurane (initially 5%, during surgery 2-3%) as 
anesthesia. For more details on the procedure see (Verheij et al., 2016). After surgery, 
the rats were allowed to recover for a minimum of 1 week before testing started. Catheter 
patency was maintained by daily sterile saline-heparin (0.3 ml; 13.5 mg/ml, 140 units/
mg) infusions.
Apparatus
All the behavioral testing took place in modular operant rat touchscreen boxes (Med 
Associates). In short, the box measured 30 x 24 x 21 cm (l x d x h) and was located 
in a sound attenuating cubicle. Near the top of the cubicle a fan was installed to push 
fresh air into the cabinet and to provide a steady background noise during the sessions. 
The floor of the touchscreen boxes consisted of 19 stainless steel rods connected to 
a shock scrambler (Med Associates). The right wall of the box contained all the typical 
operant equipment. The middle of this wall contained a pellet receptacle for sucrose 
delivery. On either side of this receptacle, a retractable lever was placed with a matching 
lever light placed above it. These levers, which were always retracted, and signal lights, 
which were always turned off, served no function during the experiments described in this 
manuscript. A house light was mounted near the top of the box above the pellet dispenser. 
The opposite wall consisted completely out of an infrared touch screen (Conclusive 
Solutions) the screen was covered with a black aluminum mask with two 10 x 10 cm 
holes placed 1 cm apart for stimulus presentation, and served as the manipulandum 
during the experiments. The door, back wall, and top of the box all consisted of clear 
Plexiglas. A spring-covered tube entered the box through the top and was connected to 
a syringe in a mechanical pump for cocaine solution delivery.
Behavioral task
The counter-conditioning task was developed specifically for these experiments and 
consisted of a pre-training phase, allowing the animals to habituate to the experimental 
chamber and the brightly illuminated touchscreen, followed by 4 distinct experimental 
phases: acquisition, counter-conditioning, extinction, and reinstatement (see below). An 
example of outcomes during the four main phases of the experiment can be found in 
figure 1. Furthermore, an overview of length of the phases and criteria for advancing to 
the next phase is available in table S1. 
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Figure 1. Overview of cue response 
contingencies. Depicted is an 
overview of the contingencies of 
responses to DS+, DScc and DS- 
cues during the 4 main phases of the 
experiment. Note that visual cues were 
counter-balanced between rats. 
Pre-training
Pre-training was divided into 3 phases: pellet training, screen training and cue training. 
Pellet training consisted of a single session during which one 45 mg sucrose pellet was 
delivered in the pellet receptacle. Upon retrieval, a 1 min inter trial interval (ITI) initiated, 
after which another pellet was delivered for a maximum of 5 pellets. During this session, 
the touchscreens were powered on and did not display any image (black screen), causing 
a slight illumination of the interior. The next day animals were placed back into the same 
chamber for screen training. During screen training, the touchscreen constantly displayed 
a dark grey image in both response areas, causing a mediocre illumination of the cage 
interior. Touching either of the response areas lead to the delivery of a sucrose pellet after 
which the screen turned off for a 1 min ITI. Rats were trained under these conditions for 1 
hour for 4 days or until a minimum of 5 pellets were collected in a single session. Next the 
rewarding visual cues which were used for typical conditioning/extinction (Discriminative 
stimulus, DS+) and counter-conditioning (DScc) were introduced in a single session, 
identical to screen training, but instead of a dark grey image DS+ and DScc images 
were presented and reinforced upon response. No DS- cues were presented during this 
session. Cues are presented in figure S1 and were counter balanced across rats. 
Acquisition 
During the acquisition phase, a pair of cues was presented for a maximum of 30 seconds. 
When rats did not respond during this period, the screen turned off for a 30 sec ITI 
after which another pair of cues was presented (missed trial). If rats responded to a 
rewarding cue (DS+ or DScc) a reward followed in the form of a 45 mg sucrose pellet or 
an infusion of 0.5 mg/kg cocaine solution depending on the cohort (correct trial). After 
delivery of the reward, the protocol proceeded to the ITI. If rats responded to a DS- cue, 
the protocol proceeded to a time-out period during which the house light was turned on 
for 30 seconds to signal unavailability of the reward followed by the ITI (incorrect trial). 
Therefore, if a rat responded to a DS- cue, the total duration of reward unavailability was 
60 seconds (versus 30 seconds on a DS+, DScc or missed trial). After the ITI the protocol 
presented a new set of images. Images were always presented as DS+/DS-, DS-/DS+, 
DScc/DS-, DS-/DScc or DS-/DS- pairs (and never as DS+/DScc or DScc/DS+ pairs, left 
cue/right cue) bringing chance responding level to 40% correct (note: chance responding 
during potentially rewarding trials, thus excluding DS-/DS- trials, was 50%). Acquisition 
sessions lasted for 1 hour for the sucrose group and 6 hours for the cocaine group. 
The latter was chosen to test the effectiveness of counter-conditioning in animals with a 
history of extended cocaine use. Primary outcomes during this phase were the number 
of rewards collected and the % of correct responses during potentially rewarding trials, 
calculated by adding CS+ and CScc responses and dividing them by the total number of 
responses during potentially rewarding trials. Animals were trained under this schedule 
for a minimum of 14 and a maximum of 30 sessions, until 80% correct responding was 
reached for 3 consecutive sessions. 
Counter-conditioning
After acquisition, the rats proceeded to the counter-conditioning phase. Counter-
conditioning was identical to the acquisition phase with the exception that DS+ responding 
was no longer rewarded and DScc responding resulted in a 0.5s, 0.25mA footshock. The 
counter-conditioning phase consisted of a single session that lasted for 1 hour. 
Extinction
During the extinction phase that followed, neither DS+ nor DScc delivered any rewards 
or shocks. Extinction lasted a minimum of 14 sessions and until there were less than 10 
combined DS+/DScc responses per session for 3 consecutive sessions. The sessions 
lasted 1 hour for the sucrose group and 4 hours for the cocaine group. 
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Reinstatement
To determine reward-induced reinstatement, a baseline measurement of responding 
was recorded for 45 min under extinction conditions, followed by the delivery of a large 
reward (5 sucrose pellets delivered in the pellet receptacle or a 10 mg/kg i.p. cocaine 
infusion, depending on the cohort). Reinstatement was then measured as a fold increase 
compared to the baseline. No further reinforcement was delivered upon DS+ or DScc 
responding. For a detailed flow schedule of the paradigm, see figure S2.
Statistics
All statistical analyses were performed by using IBM SPSS version 20 (IBM software). 
Note that rats were exposed to three cues (figure 1), allowing us to conduct within-subject 
analyses for cue effects. Data acquired during the acquisition of self-administration 
were analyzed using genotype*session repeated measures ANOVAs. The counter-
conditioning and reinstatement phase were analyzed using cue*genotype repeated 
measures ANOVA. The number of cue responses during the extinction phase of the 
cocaine cohort was analyzed using cue*genotype repeated measures ANOVA. The 
same data of the sucrose cohort were analyzed using genotype*cue type*extinction 
block univariate analysis, because some of the repeated data points were missing due 
to hardware issues. Additionally, the amount of days to criterion during the acquisition 
and extinction phases were analyzed using the Mann-Whitney U tests. Effects were 
considered significant when p<0.05 and nonsignificant effects are noted as p = NS. 
Results
Acquisition 
During acquisition, both DS+ and DScc responses resulted in the delivery of sucrose 
or cocaine, depending on the cohort. Figure 2A and 2B represents the percentage of 
correct trials during potentially rewarding trials. Repeated measures ANOVA of the data 
shown in figure 2A revealed that there was no significant genotype*session interaction 
or overall genotype effect in the sucrose cohort (interaction: F(13, 351) = 1.175, p = NS; 
genotype: F(1, 27) = 2.376, p = NS). Correct responding was above chance level after 3 
sessions for all animals and stabilized around 90% after approximately 11 sessions. In 
line with this, there was no significant difference in days-to-criterion (for criterion see 
table S1) between 5-HTT+/+ and 5-HTT-/- rats (data not shown. 5-HTT+/+: 17.56 (±0.69) 
days, 5-HTT-/-: 16.07 (±0.81) days. Mann-Whitney U test: U = 39.5, p = NS). In contrast 
to these sucrose findings, repeated measures ANOVA for the cocaine cohort revealed a 
significant genotype*session interaction (F(19,304) = 2.165, p < 0.01; figure 2B), indicating 
that 5-HTT-/- rats were more accurate over the course of this phase compared to their 
5-HTT+/+ counterparts. However, this did not result in a difference in days-to criterion 
(for criterion see table S1) between genotypes (data not shown. 5-HTT+/+: 27.57 (±0.68) 
days, 5-HTT-/-: 25.18 (±1.07) days Mann-Whitney U test: U = 19, p = NS). Figure 2C and 
figure 2D represent the pooled number of rewards collected by the sucrose and cocaine 
cohorts. We observed no differences between genotypes in either the number of sucrose 
pellets collected (figure 2C: interaction: F(11,231) = 0.804, p = NS; genotype: F(1,21) = 0.589 
, p = NS) or cocaine infusions received (figure 2D: interaction: F(19,304) = 0.545, p = NS; 
genotype: F(1,16) = 0.545, p = NS).
Figure 2. Acquisition of sucrose and cocaine self-administration in a touchscreen-based set-up in 
5-HTT+/+ and 5-HTT-/- rats. All data are represented as mean ± SEM. 5-HTT+/+ rats are represented by blue lines 
and circles and 5-HTT-/- rats are represented by red lines and squares. During this phase in the experiment rats 
were able to self-administer 0.5 mg/kg cocaine or 45 mg sucrose pellets, depending on the cohort, in response 
to 3 visually distinct, counter-balanced, cues. Figure 2A and 2B represent the percentage of correct responding 
of the sucrose and cocaine cohort, respectively, while Figure 2C and figure 2D represent the amount of rewards 
collected by both cohorts. Figure 2A shows that no differences were observed in the accuracy of acquiring the 
task in the sucrose cohort. However, in the cocaine cohort (figure 2B), 5-HTT-/- rats were more accurate in their 
responding over time (I**). Figure 2C and 2D reveal that in neither the sucrose nor cocaine cohorts the two 
genotypes showed differences in the amount of rewards collected.
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Counter-conditioning 
During a single counter-conditioning session, responses to the DScc cue were paired to 
a mild foot-shock while responding to DS+ had no programmed consequences. In the 
sucrose group, ANOVA analysis revealed a significant counter-conditioning effect (F(1,27) 
= 6.747, p<0.05) caused by lower DScc responses in the 5-HTT-/- group, as well as an 
overall genotype effect (F(1,27) = 5.3000, p<0.05) caused by the overall higher number of 
DS+ responses in the 5-HTT-/- compared to the 5-HTT+/+ rats (figure 3A). 5-HTT-/- rats 
in the cocaine group had significantly more DS+/DScc responses (figure 3B, genotype 
effect: F(1,16) = 5.466, p<0.05) and responded significantly more compared to 5-HTT
+/+ 
rats, but we observed no counter-conditioning specific effects (counter-conditioning 
effect: (F(1, 16) = 0.865, p = NS).
 
Figure 3. Counter-conditioning after sucrose or extended access cocaine self-administration. All data 
are represented as mean ± SEM. 5-HTT+/+ responding is represented using blue bars and 5-HTT-/- responding 
using red bars. For both groups the darker bars represent DS+ responding while the lighter bars represent DScc 
responding. During this single session phase DScc responses are followed by a mild footshock, while DS+ 
responding is unrewarded. Figure 3A and B show a higher response rate in 5-HTT-/- rats of both cohorts (G*). 
Additionally, in the sucrose cohort, analysis revealed a significant counter-conditioning, caused by the lower 
CScc responding in the 5-HTT-/- rats (CC*). 
Extinction
During the extinction phase, responding to neither DS+ nor DScc had programmed 
consequences. Figures 4A and B show the number of responses per cue made during 
this phase while figures 4C and D show the number of sessions required to reach the 
predefined extinction criterion (see table S1). For visual clarity, the data of the extinction 
sessions were pooled into 5 blocks (sucrose: 5 blocks of 3 sessions, cocaine: 5 blocks 
of 5 sessions). Statistical analysis of the sucrose data revealed no differences between 
genotypes (F(4,160) = 1.077, p = NS), effects of counter-conditioning (F(4,160) = 0.079, p 
= NS) or interaction (F(4,160) = 0.14, p = NS). Additionally, the data shown in figure 4C 
indicate that there was no difference between genotypes in reaching extinction criterion 
(U = 105, p = NS). In rats with extended history of cocaine intake, statistical analysis 
revealed both a significant genotype*extinction block interaction (F(4,128) = 3.141, p<0.05) 
as well as a significant overall genotype effect (F(1,32) = 6.418, p<0.05). These data are 
indicative for an overall extinction deficit in the 5-HTT-/- rats, which was independent from 
counter-conditioning. In line with this, 5-HTT-/- rats needed more extinction sessions to 
reach extinction criterion (figure 4D, U = 15.5, p<0.05). 
Figure 4. Extinction after counter-conditioning in sucrose and cocaine cohorts. All data are represented 
as mean ± SEM. Figure 4A and 4B represent the number of responses to DS+ and DScc cues split by cohort 
(sucrose and cocaine, respectively). For visual clarity the data are pooled into 5 blocks (sucrose (A): 5 blocks of 
3 sessions, cocaine (B): 5 blocks of 5 sessions) and are represented as mean ± SEM. During this experimental 
phase neither DS+ nor DScc had any programmed consequences. No differences in extinction were observed in 
the sucrose cohort (figure 4A) and genotypes did not differ in reaching extinction criterion (figure 4C). In contrast 
to this, the data in figure 4B indicate an overall deficit of extinction of cocaine seeking behavior in the 5-HTT-/- rats 
over time, which was independent from counter-conditioning (I*). In addition, these rats take longer to reach the 
extinction criterion (* Figure 4D). 
A. B.Sucrose
DS+ DScc DS+ DScc
0
5
10
15
20
CC*
G*
Cue
R
es
po
ns
es
(#
)
Cocaine
DS+ DScc DS+ DScc
0
5
10
15
20
5-HTT+/+
5-HTT-/-
G*
Cue
R
es
po
ns
es
(#
)
A. B.
C. D.
Sucrose
1 2 3 4 5
0
5
10
15
20
Extinction block
R
es
po
ns
es
(#
)
Cocaine
1 2 3 4 5
0
10
20
30
40
DS+
DScc 5-HTT
+/+
DS+
DScc 5-HTT
-/-
I*
Extinction block
R
es
po
ns
es
(#
)
Sucrose
5-HTT +/+ 5-HTT-/-
0
10
20
30
Genotype
D
ay
s
to
cr
ite
rio
n
Cocaine
5-HTT +/+ 5-HTT-/-
0
10
20
30
40
50 *
Genotype
D
ay
s
to
cr
ite
rio
n
Ch
ap
te
r 5
  |
  C
ou
nt
er
-c
on
di
tio
ni
ng
 to
 p
re
ve
nt
 re
in
st
at
em
en
t o
f c
oc
ai
ne
 s
ee
ki
ng
  
74 75
Reinstatement
To determine if reinstatement was successful, the number of DS+ and DScc responses 
were combined and compared during extinction and reinstatement conditions for both 
cohorts. Paired sample t-testing revealed that neither 5-HTT+/+ (t(12) = -0.888, p = NS) nor 
5-HTT-/- (t(10) = -0.687, p = NS) of the sucrose cohort
 increased responding significantly 
after reward administration (figure 5A). In contrast to this, reinstatement was significant 
for both genotypes in the cocaine cohort (figure 5B: 5-HTT+/+: t(6) = -2.763, p<0.05; 5-HTT
-
/-: t(10) = -2.296, p<0.05). ANOVA analysis revealed an effect of counter-conditioning on 
the fold increase of responding in both cohorts (sucrose, figure 5C: F(1,27) = 4.595, p<0.05; 
cocaine, figure 5D: F(1,16) = 6.500, p<0.05). This significant reduction in reward responding 
was observed in 5-HTT+/+ rats only, although there were no genotype (sucrose: F(1,27) = 
0.016, p = NS; cocaine: F(1,16) = 0.102, p = NS) or interaction (sucrose: F(1,27) = 2.597, p = 
NS; cocaine: F(1,16) = 1.401, p = NS) effects. 
Figure 5. Reinstatement of sucrose and cocaine taking behavior after counter-conditioning and 
conventional extinction. All data are represented as mean ± SEM. To determine whether reinstatement took 
place, the DS+ and DScc responses were added together for extinction and reinstatement conditions for both 
cohorts. Analysis revealed that reinstatement of sucrose seeking behavior (figure 5A) was not significant, while 
both genotypes reinstated cocaine seeking behavior (* figure 5B). In figure 5C-D reinstatement is expressed as 
a ratio of responding compared to a previous 45 min session under extinction conditions. In both sucrose (C) and 
cocaine (D) cohorts, counter-conditioning reduced CScc responding in 5-HTT+/+ rats only (CC*).
Discussion
Here we show that, in line with our first hypothesis, a single counter-conditioning session 
was able to reduce reinstatement of reward seeking in 5-HTT+/+ animals with a history 
of extended access to cocaine self-administration. However, contrary to our second 
hypothesis, reinstatement of reward seeking behavior was not reduced in 5-HTT-/- rats by 
counter-conditioning. In addition, we demonstrated that 5-HTT-/- rats were more accurate 
during acquisition of cocaine self-administration compared to 5-HTT+/+ rats. Furthermore, 
during the counter-conditioning session, 5-HTT-/- rats responded more persistently to 
previously rewarding cues and sucrose seeking was inhibited by foot-shocks in 5-HTT-/- 
rats. Lastly, 5-HTT-/- rats exhibited an extinction deficit after cocaine self-administration 
compared to 5-HTT+/+ rats, with no effect of counterconditioning. 
During the reinstatement session, 5-HTT+/+ rats responded less to the DScc cues 
compared to DS+ cues in both the sucrose and cocaine cohorts. This indicates that 
the within-subject task we outline above is able to replicate results obtained in the past, 
using between-subject methods in humans and animals (Bouton and Peck, 1992; Kaag 
et al., 2016; Tunstall et al., 2012; Van Gucht et al., 2010). Additionally, we show for the 
first time that counter-conditioning is capable of reducing reinstatement of rats with an 
extended access to cocaine self-administration. However counter-conditioning did not 
have an effect in 5-HTT-/- rats, in neither sucrose nor cocaine cohorts. It must be noted 
that there was no significant reinstatement in the sucrose cohort. Therefore, we should 
be careful in interpreting these results. In recent literature, sucrose seeking does not 
always lead to significant reinstatement and suggesting it may be very dependent on 
the experimental design (Kosten and Meisch, 2013; Watterson et al., 2013). However, 
despite not having significant reinstatement overall, 5-HTT+/+ rats still showed an effect in 
counter-conditioning in this cohort. Moreover, while reinstatement in the cocaine cohort is 
much more robust, the data follows the same pattern, suggesting a general insensitivity 
of 5-HTT-/- rats to counter-conditioning. As mentioned above, the existing literature 
on counter-conditioning is sparse and the literature on the underlying mechanisms is 
virtually non-existent. A notable exception to this includes the study of Kaag et al. who 
demonstrated that shock-induced counter-conditioning of monetary rewards in humans 
(appetitive to aversive switch) was associated with attenuated activation of the ventral 
striatum and VTA (Kaag et al., 2016). In line with this latter study and our results, humans 
carrying the s-allele of the 5-HTTLPR display increased ventral striatum activity during 
a simple appetitive conditioning task (Klucken et al., 2013). This suggests that low 
serotonin transporter availability may prevent top-down attenuation of striatal activity, 
thus preventing effective counter-conditioning. This is what we observed here for 5-HTT-/- 
rats. 
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During the acquisition phase, both 5-HTT-/- and 5-HTT+/+ rats receiving sucrose were able 
to acquire a task based on visual discrimination despite their albino background (Prusky 
et al., 2002). This is illustrated by the observation that all rats acquired the task quickly and 
were able to maintain an average correct response rate of 90% throughout this phase. 
However, in the cocaine cohort, 5-HTT+/+ rats were unable to maintain stable responding 
above chance levels during cocaine self-administration, caused by a higher number of 
errors (and thus still maintaining a stable cocaine intake), while 5-HTT-/- rats performed 
significantly above chance. This observation seems to be in line with the reputation of 
cocaine to reduce cognitive functioning and observations in our lab that 5-HTT-/- rats are 
more cognitively flexible compared to 5-HTT+/+ rats even after exposure to cocaine self-
administration (Nonkes et al., 2013). A reduction of cognitive functioning in 5-HTT+/+ rats 
during the acquisition phase of the cocaine task may raise the question whether these 
animals were able to distinguish the visual cues during the following phases of the study. 
However, during the reinstatement phase, 5-HTT+/+ animals were still able to distinguish 
between the DS+ and DScc cues.
There are substantial differences between the experiments described above and typical 
cocaine self-administration using levers. As discussed above, the task is more complex, 
leading to more incorrect responding when cocaine (but not sucrose) is used as a 
reward. Incorrect responding leads to a time-out period of 60 seconds (30s time-out 
plus 30 second ITI, figure S2). This feature, intended to force rats to make accurate 
responses, result in a lower number of cocaine infusions when compared to typical 
1-lever self-administration. This large difference in methodology is most likely why we did 
not observe significant genotype differences in the number of cocaine infusions during 
acquisition as previously reported (Homberg et al., 2008; Verheij et al., 2017). However, 
rats of both genotypes were still able to administer increasing amounts of cocaine during 
the experiment. Additionally, we were able to replicate the finding that 5-HTT-/- rats suffer 
impaired extinction after (typical) cocaine self-administration (Homberg et al., 2008).
In addition to this replication of extinction behavior, 5-HTT-/- rats were more persistent in 
their cocaine seeking when receiving shocks after DScc responses during the counter-
conditioning session. This is illustrated by a higher amount of both DS+ and DScc 
responses during counter-conditioning compared to 5-HTT+/+ rats, and the inability of the 
shocks to reduce DScc responding like in the sucrose group. Several researchers have 
shown insensitivity to punishment in more typical cocaine self-administration set-ups. For 
instance, Pelloux and colleagues showed that rats with an extended history of cocaine 
seeking persisted their reward seeking behavior despite receiving foot shocks at the 
time (Pelloux et al., 2007). In a subsequent study, they showed that the subgroup of rats 
that was resistant to punishment had reduced serotonergic signaling in the fronto-striatal 
circuitry, which they remediated by acute SSRI treatment (Pelloux et al., 2012). This 
suggests that there is a causal relationship between 5-HT and resistance to punishment 
in drug addiction. These reports and the data acquired in this study seem to imply that, 
while this experiment was not designed to measure this, 5-HTT-/- rats maintained drug 
seeking despite negative consequences, possibly due to reduced serotonin mediated 
top-down control. Further experiments, preferably using the seeking-taking chained 
schedule (Pelloux et al., 2007; Vanderschuren and Everitt, 2004) should be conducted to 
confirm this observation. 
Prefrontal cortex-mediated top-down control over limbic regions is essential for successful 
extinction of fear and addiction related behaviors (Peters et al., 2009). In the experiments 
described above, 5-HTT-/- rats with a history of long access to cocaine self-administration 
showed a severe extinction deficit. This is in line with many previous observations where 
5-HTT-/- rats and mice have shown extinction impairments in a variety of tests, including 
fear conditioning/extinction and short access cocaine self-administration paradigms 
(Homberg et al., 2008; Nonkes et al., 2012a; Pang et al., 2011; Schipper et al., 2011). 
Additionally, there was no effect of counter-conditioning on the extinction phase. While 
most research, including this report, seems to focus on the effect of counter-conditioning 
on reinstatement, there are some indications that it could also facilitate extinction (Tunstall 
et al., 2012; Van Gucht et al., 2010). However, these studies observed this difference 
when the extinction group, as opposed to the counter-conditioning group, is not exposed 
to any aversive conditions (i.e. without yoked/shocked control). In our experiments, all 
rats received both DS+ (no shock) and DScc (shock) conditions, which may explain the 
lack of differences in the early extinction phase. 
The current study has some limitations. Although we observed a reduction in reward 
seeking during a single reinstatement session, we have not tested the long-term effects 
of counter-conditioning. In addition, counter-conditioning has been proven to be context 
specific (Brooks et al., 1995; Peck and Bouton, 1990). The current experiments all took 
place in the same context and thus may not be directly translatable to real world situations. 
Additional experiments will need to prove if counter-conditioning can be made context 
independent by, for instance, multiple-context training or pharmacological interventions. 
In short, this work shows for the first time, that counter-conditioning can be a valid therapy 
to reduce cocaine-induced reinstatement in individuals with an extended cocaine history. 
However, individuals with altered serotonin signaling may benefit less from this therapy.
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Supplementary materials 
Table S1. Overview of experiment. Described are the presented cues, and advancement criteria for pre-
training and the 4 experimental phases. 
 Phase
Presented 
cues
Minimum advancement 
criterium
Maximum advancement 
criterium
Pretraining
Pellet training None 1 session 1 session 
Screen 
training 
Grey screen 
Minimum of 5 pellets 
collected
4 days 
Cue training DS+/DScc 1 session 1 session 
Experiment
Acquisition DS+/DScc/DS-
>80% correct on 3 
consecutive trials 
30 sessions
Counter-
conditioning 
DS+/DScc/DS- 1 session 1 session
Extinction DS+/DScc/DS-
<10 DS+/DScc responses 
after a minimum of 10 
sessions 
45 sessions 
Reinstatement DS+/DScc/DS- 1 session 1 session
Figure S1. Visual stimuli. The three used visual stimuli measured 10x10 cm and were counter-balanced across rats. Figure S2. Flow diagram of a single session during the 4 experimental phases. 
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ChapterGeneral Discussion 
“All these theories, diverse as they are, have two things in common: they explain the 
observed facts, and they are completely and utterly wrong.”
The Light Fantastic - Sir Terry Pratchett 
82 83
Cocaine addiction is a chronic relapsing disorder characterized by compulsive drug 
seeking, inability to limit intake, emergence of a negative emotional state (NES) when 
drug use is prevented (withdrawal) and the continuous taking of the drug despite 
negative consequences (DSM-5, 2013; Koob, 2009). Unfortunately, cognitive behavioral 
therapy, the first line treatment for cocaine addiction, only shows long term success in 
approximately one third of the treated patients (Dutra et al., 2008). Additionally, despite 
the enormous amount of research, there is currently no pharmacological intervention 
registered for the treatment of cocaine addiction (Potenza et al., 2011; van den Brink, 
2012). It is therefore of paramount importance that we gain more insight in the individual 
differences that cause the transition from drug use to drug addiction and that we identify 
novel targets for pharmacological intervention and/or better alternatives to cognitive 
behavioral therapy. In this thesis I used the 5-HTT-/- rat, as a model for human 5-HTTLPR 
s-allele carriers (see figure 1), to investigate the role of individual differences in the 5-HTT 
in the cause and cure of cocaine addiction. 
Naïve and cocaine induced changes in brain structure
Changes in brain white matter (WM) (Lim et al., 2002; Moeller et al., 2005) and gray 
matter (GM) (Hall et al., 2015; Ide et al., 2014) have been observed in heavy cocaine 
users. In addition, smaller GM volume has been observed in several brain structures of 
s-allele carriers of the 5-HTTLPR including the amygdala, hippocampus, orbitofrontal 
cortex (OFC), anterior cingulate cortex (ACC) and insula (Atmaca et al., 2011; Canli et 
al., 2005; Eker et al., 2011; Frodl et al., 2008; Kobiella et al., 2011; Little et al., 2014; 
Pezawas et al., 2005; Selvaraj et al., 2011). A previous study investigating brain structure 
and activity using (f)MRI/DTI in 5-HTT-/- and 5-HTT+/+ rats found few differences after 
a single injection of cocaine (van der Marel et al., 2013). However, changes in brain 
structure after chronic self-administration were not investigated. 
Therefore, in chapter 2, we used ultra-high MRI/DTI to identify changes in brain structure 
between naïve 5-HTT-/- and 5-HTT+/+ rats and in the same rats after long access to 
cocaine or sucrose self-administration. Analysis of the DTI data revealed a decrease of 
mean diffusivity (MD) in naïve 5-HTT-/- OFC, medial prefrontal cortex (mPFC) and nucleus 
accumbens (NAc), which could indicate lower cellularity in these regions (Alexander et al., 
2011). We have suggested that structural changes in these brain areas may predispose 
5-HTT-/- rats to lose control over self-administration (see below: The transition from drug 
use to drug addiction). 
After self-administration, we observed significant differences in the volume of brain 
WM and cerebrospinal fluid. In addition, region of interest (ROI) analysis revealed that, 
5-HTT-/- rats had significantly smaller amygdala volume irrespective of reward received 
while a significant interaction of genotype and reward type was observed in the DRN. 
Reduced amygdala volume has also been observed in the 5-HTTLPR s-allele carriers 
(Frodl et al., 2008; Kobiella et al., 2011; Pezawas et al., 2005) and this may very well 
contribute to the lower total tissue levels of mature and pro-BDNF observed in post-
mortem punches of the amygdala of 5-HTT-/- versus 5-HTT+/+ rats (Verheij et al., in prep.). 
The size of the DRN was positively correlated with progressive ratio (PR) breakpoint in 
the cocaine but not sucrose cohort, suggesting that this brain area plays a role in the 
motivation to self-administer cocaine. The DRN is a heterogeneous region containing, 
among others, serotonergic, dopaminergic, glutamatergic and GABAergic neurons 
(for review see: Luo et al., 2015). Additionally, the DRN projects to a large number of 
other brain areas, including the ventral tegmental area (VTA), NAc and mPFC. The 
development of optogenetic methods has allowed us to start dissecting the role these 
brain regions play in reward seeking. For instance, optogenetic stimulation of Pet-1 
containing DRN cells, which encompasses 90% serotonergic and 10% glutamatergic 
cells, is able to drive operant behavior and is modulated by 5-HT and glutamate (Liu 
et al., 2014). However, similar studies have argued that only DRN glutamatergic (and 
not serotonergic) projections projecting to dopaminergic VTA neurons cause dopamine 
release in the NAc and contribute to reward encoding (McDevitt et al., 2014; Qi et al., 
2014) and that DRN 5-HT neurons promote waiting for delayed rewards (Fonseca et 
al., 2015; Miyazaki et al., 2014). In addition, a study suggests that it may be both (Li et 
al., 2016). Interestingly, recent findings indicate decreased stress-induced serotonergic 
signaling in the DRN of 5-HTT-/- rats compared to 5-HTT+/+ controls (Schipper et al., 
2015). The authors of this work hypothesized that 5-HT1A receptors may contribute to this 
alteration in DRN activity. Furthermore, these receptors are desensitized in 5-HTT-/- rats 
and contribute to the psychomotor effects of cocaine (Homberg et al., 2008). In light of 
the studies discussed above, future experiments could focus on the role of glutamatergic 
and serotonergic DRN signaling in response to cocaine or after prolonged exposure to 
cocaine self-administration. 
The observation of total smaller WM volumes in 5-HTT-/- rats after self-administration 
should be further investigated. It has previously been observed that healthy s-allele 
carriers of the 5-HTTLPR have structural alterations in the WM of the uncinate fasciculus 
tract connecting the PFC to the amygdala, (Pacheco et al., 2009) which is hypothesized 
to reflect the lower top-down control over the amygdala in s-allele carriers (Hariri et 
al., 2002). In rats, this connection is made through the median forebrain bundle (MFB) 
(Vertes, 2004). Analysis of our high resolution DTI data of the MFB of our 5-HTT-/- rats 
may reveal similar structural changes indicative of impaired top-down control of drug 
taking behavior and, therefore, facilitate the progression to drug addiction. 
A weakness of the study described in chapter 2 was its cross-sectional nature. While 
comparable cohorts were examined under naïve conditions and after self-administration, Ch
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which can inform whether structural changes are innate or due to the behavioral paradigm, 
a longitudinal study, in which rats are scanned before, after and during self-administration 
could fully answer these issues. In addition, functional scanning in live animals, while 
giving up spatial resolution, can help us better understand the changes in brain activity 
during the switch from cocaine use to cocaine addiction. 
Dopamine, noradrenaline and serotonin
Because it has been suggested that the differences in cocaine related behaviors of the 
5-HTT-/- rats are caused by differences in dopamine or noradrenaline signaling (Oakly 
et al., 2014), we investigated the role of the three monoamine systems in response to a 
single cocaine injection in 5-HTT-/- and 5-HTT+/+ rats in chapter 3. We found that neither 
baseline nor cocaine-induced dopamine and noradrenaline levels are altered in the NAc 
or hippocampus of 5-HTT-/- rats compared to 5-HTT+/+ controls. In contrast to this, baseline 
5-HT concentrations are largely increased in both brain regions of 5-HTT-/- rats and the 5-HT 
increase upon cocaine injection is greatly blunted (but still present). This is in line with the 
fact that the 5-HTT, which is a target of cocaine, is absent. The remaining cocaine-induced 
5-HT release could reflect false serotonin reuptake into catecholaminergic neurons (Zhou 
et al., 2002) or a direct cocaine-induced release of 5-HT from storage vesicles (Verheij 
et al., 2018, Submitted). Together, these findings are in line with our hypothesis that 
increased voluntary cocaine intake is not due to changes in the positive reinforcement of 
cocaine, as this is believed to be mostly regulated by dopamine, but through serotonergic 
changes in other brain systems such as for instance CRF, but also BDNF or glutamate. 
5-HT activity can alter the activity of CRF expressing cells (Nakagami et al., 1986). 
Therefore, in addition to altered 5-HT receptor signaling as discussed above, increased 
tonic 5-HT levels may increase CRF release, which mediates negative emotional states 
(NES) (Verheij et al., 2017). Behaviorally, this may lead to decreased sucrose intake 
while cocaine intake is increased, as observed in chapter 2 (figure 1c, d). 
Treatment of cocaine dependence in 5-HTT-/- rats 
In this thesis we tried to identify new treatments that may benefit individuals with a genetic 
down regulation of 5-HTT. Chapter 4, describes the experiments in which we test if the 
partial NMDAR agonist DCS could facilitate extinction of cocaine induced conditioned 
place preference (CPP) in 5-HTT-/- rats. However, qRT-PCR suggested a lower number 
of NR1/NR2C receptors relative to NR1/NR2A and NR1/NR2B receptors in the vmPFC 
of 5-HTT-/- relative to 5-HTT+/+ rats. In line with this, a higher dose of DCS was required to 
increase extinction consolidation in 5-HTT-/- compared to 5-HTT+/+ rats. 
As discussed in this chapter, mPFC glutamateric bursting is crucial for extinction 
retention (Burgos-Robles et al., 2007). In the past, changes in NMDAR subunit mRNA 
expression have been found in human chronic alcoholics, which was mediated by 
5-HTTLPR genotype (Ridge et al., 2008). Although research showing an interaction 
between the glutamatergic and the serotonergic system is sparse, it has been suggested 
that, in the piriform cortex, 5-HT2A receptor stimulation results in weakened glutamatergic 
transmission (Carlsson, 1998; Marek and Aghajanian, 1994). Interestingly, in a more 
recent study, by Narla et al, it was shown that CRF, originating from the amygdala, can 
also reduce glutamatergic firing through activation of the CRF1 receptor (Narla et al., 
2015). Because amygdalar release of CRF is hypothesized to be increased in 5-HTT-/- 
rats after cocaine self-administration (Verheij et al., 2017), it may be that both increased 
CRF release and chronically increased extracellular 5-HT levels contribute to lower 
glutamatergic signaling. Additionally, antagonism of the CRF1R has shown to enhance 
memory of fear extinction in fear conditioned rats (Abiri et al., 2014). Therefore, future 
endeavors should focus on CRF antagonists (with or without a combination of DCS), to 
increase extinction consolidation in 5-HTT-/- rats. 
The transition from drug use to drug addiction 
Lastly, in Chapter 5, we tested whether we could decrease drug induced reinstatement 
of cocaine seeking by counter-conditioning of drug paired conditioned stimuli (CSs). We 
found that, while counter-conditioning outperformed conventional extinction in 5-HTT+/+ 
rats, 5-HTT-/- rats were unaffected by the paradigm and reinstated to both cues. In 
addition, during the actual counter-conditioning session we observed that 5-HTT-/- rats 
persisted in cocaine seeking despite receiving foot shocks at that time. It has been shown 
that approximately 20% of drug users develop addiction (Lopez-Quintero et al., 2011; 
Wagner and Anthony, 2002). While it has been suggested that this transition is, at least 
partially, dependent on individual differences, it is currently not fully understood which 
differences contribute and how (Egervari et al., 2018; Piazza and Deroche-Gamonet, 
2013). Several years ago a rat model was created based on the DSM-IV criteria for 
substance dependence (Deroche-Gamonet et al., 2004). The researchers showed 
that the propensity to relapse after a protracted (3 month) cocaine self-administration 
(SA) paradigm was predicted by the following factors: 1) persistent drug seeking during 
signaled unavailability; 2) Extremely high motivation to obtain cocaine; 3) Continued 
drug taking despite negative consequences. They found that high reinstatement rats 
scored significantly higher on all three predictor variables compared to low reinstatement 
rats. Moreover, when stratifying the rats according to the number of predictor variables 
they presented, approximately 17% of rats met all 3 criteria, a number very close to the 
number of compulsive drug takers in humans. 
Interestingly, this thesis and results obtained in the past, contain evidence that 5-HTT-/- 
rats display these three predictor variables of transition to addiction to greater extent than 
the 5-HTT+/+ rats. Firstly, 5-HTT-/- rats persist in cocaine seeking when it is unavailable 
during extinction after short (Homberg et al., 2008) and extended access to cocaine self-Ch
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administration (chapter 5; figure 4b, d). Secondly, 5-HTT-/- rats are more motivated to 
work for cocaine after short (Homberg et al., 2008; Verheij et al., 2017) and long-access 
cocaine self-administration ((Verheij et al., 2017), chapter 2; figure 1f). Lastly, chapter 5 
figure 3b shows that 5-HTT-/- rats persist cocaine seeking under negative consequences 
(i.e. footshocks). However, these predictor variables should be tested in a within subject 
longitudinal study comparing 5-HTT-/- and 5-HTT+/+ rats. Based on the results obtained 
in this thesis and other studies, we hypothesize that the percentage of 5-HTT-/- rats that 
meet all 3 predictor criteria for addiction is increased compared to 5-HTT+/+ rats. This 
would indicate that changes in the serotonergic system may contribute to the transition to 
addiction and that the 5-HTT-/- model may be used to further understand the neurological 
changes that accompany this transition and thereby provide novel targets for treatment. 
Sucrose as a control group in addiction research
In Chapter 2 and 5 we interpret the data acquired from cocaine self-administering rats 
relative to that of sucrose self-administering rats. The choice of control groups in any 
scientific experiment is important for the interpretation of results. When conducting 
cocaine self-administration experiments, several different control groups can be selected. 
Drug-naive controls, as also used in chapter 2, usually do not control for effects caused 
by altered home cage conditions, daily testing and surgery, and cannot always be used. 
A sucrose group, like used in chapter 2 and 5 controls for effects of daily testing and 
surgery (granted that sham surgery is performed on animals receiving oral sucrose), and 
is often selected as a rewarding, but non-addictive, control (Chen et al., 2008; Gao et al., 
2018; You et al., 2007). In recent years, the addictive versus non-addictive properties of 
sucrose (and other highly palatable foods) have been receiving some attention (for review 
see: Ahmed et al., 2013). While it is true that consumption of sucrose can activate similar 
brain regions as other addictive drugs (Tang et al., 2012), Rada et al showed that sucrose 
administration fails to increase DA release once the food is no longer novel or the animal 
no longer hungry (Rada et al., 2005). Additionally, animals who have access to sucrose in 
a binge like fashion, such as in the experiments described in this thesis, will compensate 
their caloric intake in the homecage (Avena et al., 2009), and will stop sucrose seeking 
under negative consequences (footshocks) (Limpens et al., 2014). Therefore, sucrose is 
generally not accepted as an addictive substance (Ziauddeen et al., 2012) making this a 
valid control for many self-administration experiments. 
Alternatively, one can compare the drug taking habits of short access self-administering 
animals to that of long access self-administering animals, as the former is thought to 
measure non-compulsive drug use and the latter compulsive drug use (Ahmed and Koob, 
1998). Or, alternatively, separate long access self-administration animals into cohorts 
depending on how many criteria of drug addiction they present (see: The transition 
from drug use to drug addiction section above). While these models may be better at 
answering questions regarding the transition from regular drug use to drug addiction, 
they may not be ideal for dissecting out the effects of cocaine per se. When interested 
in dividing the pharmacological effects of cocaine form the associative process (drug 
CSs) it is possible to include a yoked control group, which receives the same amount of 
cocaine or saline as another rat, but has no control over self-administration (Chen et al., 
2008; Hyman et al., 2006; You et al., 2007) 
Ideally, one includes several control groups to exclude as many external factors as 
possible, depending on the research questions. 
Clinical implications
No single drug addiction treatment is appropriate for all individuals, thus treatments need 
to be customized to take into account the type of drug and the genetic characteristics of 
the patient (NIDA, 2018). Carrying the 5-HTTLPR s-allele as a risk factor for developing 
substance abuse disorders (SADs) is well-established and is mirrored in the 5-HTT-/- rat 
model (Cao et al., 2013, Chapter 2; Enoch et al., 2011; Feinn et al., 2005; Gerra et al., 
2007; Gokturk et al., 2008; Homberg et al., 2008; Martin-Santos et al., 2010; Verheij et 
al., 2017). However, if and to what extent the 5-HTTLPR contributes to the effectiveness 
of (pharmacological) interventions of cocaine addiction remains largely unknown. There 
are some studies that, in line with our results obtained in chapter 4 and 5, show an 
effect of 5-HTTLPR genotype on treatment outcome for alcohol (Johnson et al., 2011), 
opioid (Crist et al., 2018) and cocaine (Nielsen et al., 2012) addiction. While the results 
obtained by Johnson and colleagues and Crist and colleagues are in line with our own 
findings, reduced effectivity is s-allele carriers, Nielsen and colleagues actually suggest 
an increased effectivity of disulfiram. However, while this finding is promising, the Nielsen 
study consists of preliminary data in a small number of patients and therefore requires 
replication and/or expansion in order to be generally accepted. 
As mentioned above, there is currently no registered pharmacological intervention 
for cocaine dependence. However, there are currently a number of treatments under 
investigation in clinical settings, ranging from glutamatergic (Duailibi et al., 2017) agents 
to deep brain stimulation (Goncalves-Ferreira et al., 2016) and transcranial direct current 
stimulation (Batista et al., 2015). When effectiveness of these interventions is determined 
in large phase III/IV cohorts it would be interesting to test if the 5-HTTLPR genotype of 
the patient modulates effectiveness. However, at the same time, we must remember that 
the effect size of a single gene in a disorder as complex is generally small. Therefore, 
simultaneous research into other genetic risk factors will be the key to developing 
individualized therapy for the addicted patient. 
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ChapterSummaries
“In a dark place we find ourselves, and a little more knowledge lights our way.”
Yoda (Star Wars Episode III: Revenge of the Sith) 
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English summary 
Cocaine addiction is a chronic relapsing disorder characterized by compulsive drug 
seeking, inability to limit intake, emergence of a negative emotional state (NES) when 
drug use is prevented (withdrawal) and the continuous taking of the drug despite negative 
consequences. Humans carrying the short version of the serotonin-transporter-linked 
polymorphic region (5-HTTLPR) are at an increased risk to develop several addiction 
types, including cocaine addiction. In this thesis we use the 5-HTT-/- rat to model the 
human s-allele of the 5-HTTLPR. 
In chapter 1 we discuss the brain regions and neurotransmitters involved in addiction 
as well as the role of Pavlovian learning and the emergence of a negative emotional 
state (NES) contributing to addiction. We also introduce the 5-HTTLPR and 5-HTT-/- rat. 
Additionally, we provide the aims of this thesis as investigating the cause of increased 
addiction susceptibility in 5-HTT-/- rats as well as investigating potential cures that might 
be used as individualized therapy.
In chapter 2 we discuss an ultra-high structural MRI/DTI study of naïve 5-HTT-/- and 
5-HTT+/+ rats and similar rats after long-access to cocaine or sucrose self-administration. 
In this study, we show a reduction in mean diffusivity (MD) in the medial prefrontal cortex 
(mPFC), anterior cingulate cortex (ACC) and nucleus accumbens (NAc) of naïve 5-HTT-
/- rats compared to 5-HTT+/+ counterparts, possibly indicating lower cellularity in these 
areas. Additionally, after self-administration, region of interest (ROI) analysis revealed 
5-HTT-/- rats had significantly lower amygdala volume irrespective of reward received while 
a significant interaction of genotype and reward type was observed in the dorsal raphe 
nucleus (DRN). Interestingly, the size of the DRN was associated with the progressive 
ration breakpoint in cocaine but not sucrose, indicating that this region may play a role in 
the motivation to take cocaine.
It has been suggested that the differences in stimulant self-administration in 5-HTT-/- rats 
are caused by changes in dopamine (DA) or noradrenaline (NA) signaling. Therefore, 
in chapter 3, we measured the release of 5-HT, DA and NA in vivo at baseline and in 
reaction to a single injection of cocaine using microdialysis of the NAc and hippocampus. 
We observed no differences in baseline or cocaine induced DA and NA levels in either 
brain region. We conclude that this indicates that these neurotransmitters probably 
don’t play a major role in the 5-HTT-/- rat drug taking phenotype. However, in both brain 
regions, baseline extracellular 5-HT was increased in 5-HTT-/- rats compared to 5-HTT+/+ 
rats and the extracellular 5-HT increase after cocaine injection was blunted suggesting 
that 5-HT induced changes in de (re)activity of non-catecholaminergic systems may play 
an important role in individual differences in the response to cocaine. 
In chapter 4 we attempt to increase extinction consolidation of cocaine associated cues 
by intravenous administration of D-cycloserine (DCS), a partial NMDA receptor agonist. 
However, qRT-PCR suggested a lower number of NR1/NR2C receptors relative to NR1/
NR2A and NR1/NR2B receptors in the mPFC of 5-HTT-/- relative to 5-HTT+/+ rats. In 
line with this, a higher dose of DCS was required to increase extinction consolidation in 
5-HTT-/- compared to 5-HTT+/+ rats in a cocaine induced conditioned place preference 
task. 
In chapter 5 we attempt to capitalize on the behavioral flexibility of the 5-HTT-/- rat in 
a counter-conditioning paradigm. During acquisition of self-administration, two visual 
stimuli are paired to sucrose or cocaine-self administration. Subsequently, one cue is 
paired to a mild footshock (counter-conditioning) while the other is paired to nothing 
(conventional extinction training). We then tested if reward-induced reinstatement 
occurs to both stimuli. While the counter-conditioning paradigm was able to outperform 
typical extinction training in 5-HTT+/+ rats, 5-HTT-/- rats did not seem to benefit from this 
behavioral approach.
Chapter 6 summarizes our findings and discusses them in a broader context. 
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Nederlandse samenvatting
Cocaïne verslaving is een chronische terugkerende stoornis gekenmerkt door compulsief 
cocaïne gebruik, het onvermogen om gebruik te verminderen, het ontwikkelen van 
een negatieve emotionele staat (NES) als cocaïne gebruik wordt voorkomen en het 
doorgaan met cocaïne gebruik ondanks negatieve consequenties. Serotonine (5-
HT) is een belangrijke neurotransmitter die vele processen in het brein reguleert. De 
extracellulaire concentratie van deze neurotransmitter wordt veelal gereguleerd door de 
5-HT transporter (5-HTT). Mensen die de korte (s) versie van het ‘serotonin-transporter-
linked polymorphic region (5-HTTLPR)’ in de promotor regio van het 5-HTT gen dragen, 
hebben een hogere kans op het ontwikkelen van verschillende soorten verslaving, 
waaronder cocaïne verslaving. In dit proefschrift hebben wij de serotonine transporter 
knockout rat (5-HTT-/- rat) gebruikt als model voor mensen die drager zijn van het s-allel 
van het 5-HTTLPR.
In hoofdstuk 1 bespreken wij de gebieden in het brein en de neurotransmitters die een 
rol spelen in verslaving. Ook bespreken we hoe Pavloviaans leren en het ontstaan van 
een NES bijdragen aan het verslavingsproces. Eveneens introduceren wij het 5-HTTLPR 
en de 5-HTT-/- rat. We sluiten dit hoofdstuk af met het vermelden van de doelen van dit 
proefschrift: het onderzoeken van de oorzaak van de hogere verslavingsgevoeligheid 
in 5-HTT-/- ratten evenals het onderzoeken van potentiele behandelingen die gebruikt 
zouden kunnen worden als persoonsgerichte therapie.
In hoofdstuk 2 bespreken we een studie waarin ultra hoge resolutie MRI/DTI gebruikt 
wordt in naïeve 5-HTT-/- en 5-HTT+/+ ratten evenals gelijksoortige ratten die langdurig 
toegang hebben gehad tot cocaïne of sucrose zelftoediening. In deze studie vinden wij een 
lagere ‘mean diffusivity’ (MD) in de mediale prefrontale cortex (mPFC), ‘anterior cingulate 
cortex’ (ACC) en ‘nucleus accumbens’ (NAc) van naïeve 5-HTT-/- ratten in vergelijking 
met 5-HTT+/+ controle ratten wat mogelijk impliceert dat er een lagere cellulariteit in 
deze gebieden. Na zelf-toediening bleek uit ‘region of interest’ (ROI) analyse dat 5-HTT-
/- ratten een significant lager amygdala volume hebben ongeacht welke beloning werd 
ontvangen. Eveneens was er een significante interactie van genotype en beloning type 
in het volume van de dorsale raphe nucleus (DRN). Verdere correlatie analyse liet zien 
dat er een relatie is tussen DRN volume en de motivatie om cocaïne, maar niet sucrose, 
toe te dienen. 
In eerder onderzoek werd gesuggereerd dat het verschil in psychostimulantia zelf-
toediening in 5-HTT-/- ratten veroorzaakt zou kunnen worden door veranderingen 
in dopamine (DA) en noradrenaline (NA) signalering. Om dit te testen hebben we in 
hoofdstuk 3 de extracellulaire concentraties van 5-HT, DA en NE gemeten, in vivo, 
op baseline en na een enkele injectie cocaïne in de NAc en de hippocampus. In beide 
hersengebieden vonden we geen verschillen in baseline of cocaïne geïnduceerd NA 
of DA niveaus. Echter, in beide gebieden was baseline 5-HT verhoogd en was de 
cocaïne geïnduceerde 5-HT afgifte afgestompt in 5-HTT-/- versus 5-HTT+/+ ratten. Deze 
resultaten suggereren dat 5-HT geïnduceerde veranderingen in de (re)activiteit van 
non-catecholaminerge systemen een belangrijke rol kunnen spelen in de individuele 
verschillen in de reactie op cocaïne. 
In hoofdstuk 4 hebben we geprobeerd om de extinctie consolidatie te verbeteren van 
cocaïne geassocieerde stimuli door intraveneuze toediening van D-cycloserine (DCS), 
een partiele NMDA receptor agonist. Echter, qRT-PCR suggereerde een lager aantal 
NR1/NR2C receptoren in vergelijking met NR1/NR2A en NR1/NR2B receptoren in de 
mPFC van 5-HTT-/- versus 5-HTT+/+ ratten. In lijn met deze bevinding hadden 5-HTT-
/- ratten, in vergelijking met 5-HTT+/+ ratten, een hogere dosis DCS nodig voor extinctie 
consolidatie van een cocaïne geïnduceerd ‘conditioned place preference test’. 
In hoofdstuk 5 proberen we de verbeterde cognitieve flexibiliteit die de 5-HTT-/- rat 
in het verleden heeft laten zien te gebruiken in een ‘counter-conditioning’ paradigma. 
Tijdens de acquisitie fase worden twee visuele stimuli gepaard aan sucrose of cocaïne 
zelf-administratie. Hierna wordt één stimulus gepaard aan een milde schok (‘counter-
conditioning’) en de andere wordt aan niets gepaard (conventionele extinctie training). 
Vervolgens testen we beloning geïnduceerde herstelling van beloning zoekgedrag voor 
beide cues. Ondanks dat ‘counter-conditioning’ beter werkt dan conventionele extinctie in 
5-HTT+/+ ratten om zoekgedrag te verminderen lijken 5-HTT-/- ratten geen baat te hebben 
bij deze gedragsmatige interventie.
Hoofdstuk 6 geeft een samenvatting van de gevonden resultaten en plaatst deze in een 
bredere context.
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Appendices: 
“He came like the wind, like the wind touched everything and like the wind was gone.”
Loial (A Memory of Light - Robert Jordan) 
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Dankwoord
Welkom beste lezers in het meest gelezen maar minst gereviewde stuk uit dit hele 
proefschrift. Zoals jullie waarschijnlijk wel weten doorloop je een promotietraject nooit 
alleen. Het werk wat in dit boekje staat, is zeker niet mogelijk geweest zonder een 
significante bijdrage van een groot aantal anderen. Hieronder wil ik jullie allemaal even 
in het zonnetje zetten. 
We beginnen traditiegetrouw (en terecht) met het promotie team. Judith, Michel en 
Liesbeth. Jullie wil ik natuurlijk eerst gezamenlijk bedanken voor jullie wetenschappelijke 
input, tijd en toewijding die jullie aan dit project hebben bijgedragen. Judith, wij kennen 
elkaar al bijna 9 jaar! In die tijd heb ik veel van je geleerd en heb je me altijd vrij gelaten 
om mijn eigen ideeën te implementeren. Ontzettend bedankt voor de fijne samenwerking 
de laatste jaren. Meneertje Verheij, jij werd iets later bij het project betrokken, maar jou 
praktische kennis is sindsdien onmisbaar voor me geweest. Jouw (soms iets te) kritische 
oog heeft de manuscripten een stuk beter gemaakt en is cruciaal geweest voor het 
geaccepteerd krijgen van de papers. Liesbeth, ik vond de besprekingen in Amsterdam 
met Wim, Anne-Marije en Guido altijd heel prettig, het was goed om soms een andere 
blik op de data te krijgen. Het counter-conditioning experiment was nooit van de grond 
gekomen zonder jullie input.
Mieke en Martijn. Jullie staan vandaag naast me als mijn paranimfen. Mieke, mijn kleine 
zusje, jij bent zelf ook aan een PhD begonnen dus het is een goede oefening voor je 
eigen verdediging over een paar jaar. Ik vond het erg leuk om iemand in het gezin te 
hebben waarmee ik het reilen en zeilen van onderzoek kon bespreken. Hopelijk heb ik 
in de afgelopen jaren een mooi voorbeeld gegeven hoe het (niet?) moet. Ik merk dat je 
de afgelopen tijd een goed speciaal biertje steeds meer bent gaan waarderen, dus laten 
we binnenkort hier samen eens eentje drinken. Martijn, wij kennen elkaar al jaren en 
jaren. Dit kun je wel merken aan het aantal keer dat je nog terugkomt in dit dankwoord. 
Samen met jou over wetenschap (en andere dingen) praten tijdens lunch, koffiepauze 
of in de Aesculaaf (met een speciaal biertje) kan ik altijd waarderen. Samen gamede 
we regelmatig op vrijdagochtend voordat we aan het werk gingen (soms iets langer 
dan gepland…oeps). We maakte samen gigantische fabrieken, slachtten monsters af, 
koloniseerde eilanden, en trokken door Azeroth. Hopelijk houdt deze pret nooit op (LAN 
party in het bejaardenhuis!). Bedankt voor alles, ik ben vereerd dat jullie vandaag naast 
me staan. 
Zoals gezegd doe je een promotie nooit alleen, je wordt altijd geholpen door je collega’s 
die in hetzelfde schuitje zitten als jij. Toen ik begon aan dit traject was de afdeling nog 
klein. Pieter, Rick, Yvet, Anthonieke en Lourens samen met Sjef, Ruben en Michel; met Ap
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z’n allen (en een klein legertje studenten) zaten we op het CDL. De goede oude tijd van 
koffie en tosti’s op het kantoor en heerlijke biertjes in de Aesculaaf (of kantoor). Elkaar 
helpen bij het in elkaar zetten van twijfelachtige opstellingen die aan elkaar hingen met 
schildertape en werden opgenomen op old-school videobanden. In de loop der jaren 
zijn er nog velen bijgekomen Deborah, Noortje, Elisavet, Marloes, Giuseppe, Sabrina, 
Anne-Marie, Giacomo, Sandra, Yacine, Marcia, Chao, Mina en Danielle. Met jullie heb ik 
natuurlijk ook de nodige tijd doorgebracht in de Aesculaaf, bij movie nights, op congres, 
en (in sommige gevallen) zelfs op vakantie. Vrouwen van het secretariaat, jullie mogen 
ook zeker niet ontbreken. René, Ellen, Erna, Inge. Jullie zorgden er altijd voor dat alles 
in goede banen werd geleid op de afdeling. Daarnaast zorgden jullie ook voor de nodige 
gezelligheid in en om het kantoor. Ook alle medewerkers van het CDL, in het bijzonder 
Karin, Maikel, Alex, Alex, Helma, Janneke en Jeroen wil ik van harte bedanken voor al 
hun hulp en goede zorg.
Uiteindelijk werd zelfs aan mij een toekomstige generatie aan wetenschappers 
toevertrouwd. Benthe, Alexandra, Marlous, Bas, Emma, Amanda en Jeffrey. Ik vond het 
erg leuk om jullie tijdens jullie stages te begeleiden. Heel erg bedankt voor jullie bijdragen! 
Immunohistochemisch werk voor dit boekwerk werd vaak verricht op de afdeling 
Anatomie. Hier werden ik en mijn studenten (die daadwerkelijk het werk deden) oneindig 
ondersteund door Jos en Bram. Ook een gezellig babbeltje hadden ze altijd voor me 
klaar. Mannen bedankt! 
Sommige van de beschreven experimenten zijn ook in Utrecht uitgevoerd. Hiervoor wil ik 
ten eerste graag Rick en Louk bedanken voor de gastvrijheid op hun afdelingen en ook 
voor hun wetenschappelijke input tijdens de opzet van deze en andere experimenten. 
Ook Annette en Han mogen niet ontbreken in het rijtje van mensen die onmisbaar zijn 
geweest in de afgelopen jaren. Daarnaast wil ik graag Helma en Anja bedanken voor de 
goede zorg van de Utrechtse diertjes als ik niet aanwezig was. 
BMWers! Jeroen, Geert, Annemiek, Lisanne, Dorien, Luc, Maud en Martijn. Jullie wil ik 
allemaal bedanken voor alle gezellige avonden door de jaren heen. De leuke borrels, 
weekendjes, feestjes, ski trips etc. Jullie zijn de afgelopen jaren onmisbaar geweest voor 
de mentale stabiliteit van deze wetenschapper.
Biologen! Daan, Vivian, Ton, Yvette, Harriëtte, Adriaan, Dick, Elisavet, Klaas, Marloes, 
Jan-Willem, Rosanne, Lena, Sebastian, Sjoerd, Iolanda, Léonie, Gert-Jan, en Tim. 
Bedankt dat jullie me geadopteerd hebben in jullie vriendengroep. Biertjes drinken, met 
20 man op weekendjes weg, verkleden als Harry Potter (Slytherin!), skiën en talloze 
verhuizingen. Het is altijd gezellig met jullie! 
James, Gromli, Elphirion, Blehar, Gul’khar, Barbin en Zoltan. Bedankt dat jullie deze 30 
jarige nerd helpen bij het ontdekken van een nieuwe hobby. Ik kijk reikhalzend uit naar 
elke nieuwe sessie (en de biertjes die daarmee gepaard gaan). 
Marvick en Robbert. Al vrienden sinds de middelbare school, en alles is zoals van ouds 
als we (met Martijn) samen in dezelfde kamer zijn. Kaartje leggen, beetje kletsen en de 
cryptische aantekeningen van een van de vorige avonden proberen te ontcijferen om er 
achter te komen welk kaartspel we ook alweer gespeeld hebben. Natasja, altijd leuk om 
avondjes met jou (en Martijn) in te plannen. Beetje grappen en grollen, en na een paar 
pilsjes zit er nog wel een (Carlton of Apache) dansje in. Kortom, altijd gezellig!
Yolba, Genevieve, Joline en Charlotte (en Willem). Samen bezetten we ons kleine 
kamertje bij de Hematologie. Ijsjes eten in de zon, bouncen op de kruk, meezingen met 
ABBA en af en toe ook nog werken. Altijd gezellig op de kamer. Team EUMDS! Theo, 
Corine en Karien. Bedankt voor de prettige samenwerking en de interesse naar de 
vordering van mijn proefschrift. Hierbij wil ik ook de rest van de hematologie en integraal 
collega’s betrekken. 
Harrie, Ronald en Chantal. Fijn om altijd welkom te zijn bovenaan de heuvel in Heerlen 
of in Den Haag. Lekker met een speciaal biertje of een Pauline uit de kelder op de 
bank bijpraten of relaxen in de tuin. Menig uurtje is ook gespendeerd aan de eettafel in 
Heerlen met een kopje koffie werkend aan dit boekje. 
Pap en mam, jullie staan altijd voor me klaar. Een aanmoedigend woordje wanneer dit 
maar nodig is. Een verblijf in hotel mama is altijd zonder zorgen. Lekker in de tuin met 
de vuurkorf aan of in de keuken helpen met een van de nieuwste gerechten van mams 
kookcursus. Bedankt dat jullie altijd in mij hebben geloofd.
Mieke, Max, Marianne, Elvira & Elin. Wie had ooit kunnen denken dat er een einde zou 
komen aan dat promotie traject wat jullie broer/zwager/oom ooit gestart is. Jullie hebben 
er in ieder geval nooit aan getwijfeld (in tegenstelling tot mijzelf soms). Bedankt voor alle 
getoonde interesse en steun! 
Deborah, zonder jou had ik dit niet kunnen doen. We begonnen ooit als collega’s, werden 
vrienden en dit groeide uit tot de liefde van mijn leven. Jou steun, begrip en humor 
hebben mij door de laatste jaren heen gesleept. Je hebt mij weten te motiveren toen ik 
er helemaal klaar mee was en me op weten te vrolijken tijdens de diepste dalen. Samen 
vieren we de pieken met een heerlijk flesje wijn en een knabbeltje of een rijsje naar 
Nieuw-Zeeland, Parijs of naar de ski pistes in Oostenrijk. Ontzettend bedankt, ik hou 
enorm veel van je! 
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Data management and the FAIR priniciples. 
According to the FAIR data principles, scientific data should be Findable, Accessible, 
Interoperable and Re-usable. Because data gathering for this thesis was completed 
before the FAIR principles were published and adopted by the Radboudumc, no 
systematic approach to FAIR data management has been applied to these data. 
However, all acquired data will be centrally stored under the stewardship of Dr. J.R. 
Homberg, including all laboratory journals and protocols. This way the data is accessible 
for re-use by individuals under the supervision of Dr. Homberg. In addition, Dr. Homberg 
is registered as the corresponding author for the data described in this thesis and data is 
available for external parties upon reasonable request. 
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PhD training 
Courses 
2016: Basic course legislation and organization (BROK) 
2015: Good Clinical Practice (GCP) course 
2013: Writing in the Sciences 
2013: Statistics in medicine 
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2011-2016 Weekly Translational neuroscience Unit meeting 
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2013: InDesign Workshop 
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2012: Invited speaker, Dutch Neuroscience Meeting 
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Donders Graduate School for Cognitive Neuroscience
For a successful research Institute, it is vital to train the next generation of young 
scientists. To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour 
established the Donders Graduate School for Cognitive Neuroscience (DGCN), which 
was officially recognised as a national graduate school in 2009. The Graduate School 
covers training at both Master’s and PhD level and provides an excellent educational 
context fully aligned with the research programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of the 
best and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, e.g. 
Stanford University, University of Oxford, University of Cambridge, UCL London, MPI 
Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, North 
Western University, Northeastern University in Boston, ETH Zürich, University of Vienna 
etc.. Positions outside academia spread among the following sectors: specialists in a 
medical environment, mainly in genetics, geriatrics, psychiatry and neurology. Specialists 
in a psychological environment, e.g. as specialist in neuropsychology, psychological 
diagnostics or therapy. Positions in higher education as coordinators or lecturers. A 
smaller percentage enters business as research consultants, analysts or head of research 
and development. Fewer graduates stay in a research environment as lab coordinators, 
technical support or policy advisors. Upcoming possibilities are positions in the IT sector 
and management position in pharmaceutical industry. In general, the PhDs graduates 
almost invariably continue with high-quality positions that play an important role in our 
knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/
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